Understanding the Relationship of Bile Acid Binding Capacity, Phenolic Compounds and Their Bioaccessibility of Selected Vegetables by Yang, Isabelle Fan
UNDERSTANDING THE RELATIONSHIP OF BILE ACID BINDING CAPACITY, 
PHENOLIC COMPOUNDS AND THEIR BIOACCESSIBILITY OF SELECTED 
VEGETABLES 
A Thesis 
by 
ISABELLE FAN YANG 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
MASTER OF SCIENCE 
Chair of Committee,  Bhimu Patil 
Committee Members, Nancy D. Turner 
Joseph M. Awika 
G.K. Jayaprakasha 
Head of Department, Boon Chew 
August 2017 
Major Subject: Food Science and Technology 
Copyright 2017 Isabelle Fan Yang 
ii 
ABSTRACT 
       Vegetables with bile acid capacity provide multiple benefits to human health, including 
reducing plasma cholesterol levels, controlling blood sugar in type 2 diabetic patients, and 
preventing colon cancer. The in vitro bile acid binding capacities of Brussels sprouts, green 
kale, red kale, red cabbage, and red leaf lettuce were tested and their dietary fiber content 
was analyzed. Green kale was used for further studies to explore the optimal dose for bile 
acid binding, the effect of bile acid composition on the binding capacity, the influence of 
minimal processing on the bile acid binding capacity, the interaction of bioactive compounds 
with bile acids, and the impact of bile acids on the bioaccessibility of kale polyphenols. 
       The in vitro digestion was conducted in three phases that simulated oral, gastric, and 
intestinal digestion. Bile acids were incubated with vegetables in the intestinal digestion 
phase. Kale had the greater bile acid binding capacity compared with Brussels sprouts, red 
cabbage, and red leaf lettuce. In the experiment testing the effect of different bile acid 
compositions on bile acid binding capacity, kale showed a similar binding capacity for the 
bile acid composition simulating that found in healthy females and males with gallstones, but 
it bound less bile acids when the composition simulated the bile acid pool of type-2 diabetic 
males. The type-2 diabetic male patient model was used to explore bile acid binding 
capacity in response to different doses of kale. The results suggested that the optimal dose of 
kale was 1.8 g, which bound 81.8% of the added bile acid. Microwaving and steaming 
significantly improved kale’s in vitro bile acid binding capacity. 
       To study the interaction between bile acids and different bioactive compounds in kale, 
polyphenols were separated from the fiber-rich kale tissue, and both of these were incubated 
 iii 
 
with bile acids. We found that the fiber-rich tissue in kale was the main component that binds 
bile acids. Similar in vitro digestions both with and without bile acids suggested that bile 
acids improved the bioaccessibility of quercetin and the total identified polyphenols in kale. 
Therefore, bile acids can be bound by fiber rich tissues in the kale and have some interactions 
with kale polyphenols. 
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CHAPTER I 
 INTRODUCTION 
       Bile acids are emulsifiers that facilitate the digestion of fat. These amphipathic 
molecules have a hydrophilic side and a hydrophobic side and can surround fat globules in 
the aqueous environment to form a lipid drop. Lipases can then attach to the lipid drop and 
assist with fat digestion. Bile acids are synthesized from cholesterol in the liver, stored in the 
gallbladder, and enter the small intestine when fatty food is in the digestive system. The 
human body has fourteen bile acids: two of them are primary bile acids, namely cholic acid, 
chenodeoxycholic acid,1 and two of them are secondary bile acids, namely deoxycholic acid 
and lithocholic acid. Each of these four bile acids can attach to taurine or glycine in the liver 
and form conjugated bile acids. Our bodies also have a trace amount of ursodeoxycholic 
acid.2 Unconjugated bile acids are more hydrophobic than conjugated bile acids, which are 
more toxic to liver and colon cells.3 Deoxycholic acid and lithocholic acid can even promote 
colon cancer.4 Therefore, binding bile acids through foods can protect the colon and liver and 
also promote the synthesis of new bile acids from cholesterol, which consequently reduces 
plasma cholesterol levels.    
         Various vegetables have in vitro bile acid binding capacity, including beets, collard 
greens, kale, mustard greens, broccoli, Brussels sprouts, and spinach.5 These vegetables are 
rich in dietary fiber, which is commonly considered as the component that binds bile acids. 
Red cabbage, red kale, green kale, Brussels sprouts, and red leaf lettuce all contain a good 
amount of dietary fiber and other nutrients. Red cabbage and red leaf lettuce have 
glucosinolates and anthocyanins.6 The glucosinolates in Brussels sprouts can lower the risk 
of  cancer.7 Kale has lutein, chlorophyll, glucosinolates, and polyphenols.8-10 Among these 
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vegetables, green kale has a  higher content of antioxidants, which is due to its abundant 
polyphenols.11  
       In addition to digestion emulsification, bile acids also assist in the absorption of some 
nutrients in vegetables, such as beta-carotene, lycopene, and lutein. When bile acids are 
absorbed through the ileum and pass into the blood stream, they carry along the liposoluble 
nutrients.12 Yet, dietary fiber in the plant can bind bile acids and affect bile acid absorption. It 
can bind bile acids and potentially reduce cholesterol levels and protect the liver and the 
colon. However, not all bile acids are toxic to the liver or colon; some hydrophilic bile acids, 
such as tauroursodeoxycholic acid, have protective functions in the human body.3 Therefore, 
it is necessary to study the binding capacities for hydrophilic and hydrophobic bile acids 
separately. Even though vegetables’ in vitro bile acid binding capacity has been investigated 
before,5, 13 few studies have examined the binding capacity of individual bile acids.  
       Bile acids can be bound by dietary fiber, and also by some polyphenols. For example, 
Ngamukote found grape polyphenols can bind bile acids and reduce cholesterol levels.14 It is 
possible that the phenolic compounds in the vegetables may also contribute to in vitro bile 
acid binding capacity. On the other hand, bile acids may affect absorption of polyphenols in 
the digestive system because during digestion, dietary fiber can bind bile acids and can also 
trap some phenolic compounds.12 Therefore, bile acids might influence the bioaccessibility of 
polyphenols, since they both can interact with dietary fiber. According to the best of our 
knowledge, the effect of bile acids on polyphenol bioaccessibility has not yet been studied. 
       This research was designed to study the in vitro binding capacity for total and individual 
bile acids by kale, Brussels sprouts, red leaf lettuce and red cabbage. The interaction of bile 
acids with dietary fiber and kale polyphenols was also explored. 
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CHAPTER II 
 LITERATURE REVIEW 
Bile Acids 
       The human liver can synthesize primary bile acids — cholic acid and chenodeoxycholic 
acid — from cholesterol, and the bacteria in the intestine can transform primary bile acids 
into secondary bile acids, namely lithocholic acid and deoxycholic acid.15 When these 
unconjugated bile acids bind to taurine and glycine, conjugated bile acids are formed, 
including taurocholic acid, taurodeoxycholic acid, taurochenodeoxycholic acid and 
taurolithocholic acid, glycodeoxycholic acid, glycochenodeoxycholic acid, and 
glycolithocholic acid. The bacteria in the human gastric intestinal tract can deconjugate the 
taurine-formed and glycine-formed bile acids and transfer them back into unconjugated bile 
acids.16  
       When the human digestive system breaks down fat, bile acids assist digestion by acting 
as emulsifiers in the intestine. During digestion, 95% of bile acids are reabsorbed through the 
ileum and transferred back to the liver; only 5% of bile acids are excreted out of the human 
body.2 Because bile acids are reabsorbed, the human bile pool remains constant; therefore, 
effective bile acid recycling suppresses the synthesis of new bile acids from cholesterol. 
Meanwhile, the modern western diet has large amounts of lipids, which can contribute to the 
accumulation of cholesterol in the human body, and may develop into hypercholesterolemia 
or cardiovascular diseases if it is not controlled.1, 2  Binding bile acids can contribute to the 
reduced cholesterol levels in blood and have protective function to hypercholesterolemia and 
cardiovascular disease.  
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       Besides preventing hypercholesterolemia, binding bile acids can also lower the risk of 
colon cancer, since free bile acids in the colon irritate the colon cells and cause diarrhea, and 
hydrophobic bile acids, such as deoxycholic acid, chenodeoxycholic acid, can increase the 
potential of developing colon cancer.17 In addition, Prawitt suggested that bile acids can 
activate a farnesoid X receptor (FXR), which is an inhibitor of hepatic glucose production 
and can regulate glucose metabolism.18 Thus, binding bile acids can contribute to the control 
of blood sugar levels in type 2 diabetic patients.  
       People with malabsorption of bile acids may have too much free bile acid in their large 
intestine, which irritates the intestinal cells and causes diarrhea. And also, the bacteria in the 
intestine may release bound bile acids from the fiber, deconjugate the conjugated bile acid 
and form more secondary bile acids, which are more toxic to intestinal cells. In this case, bile 
acid sequestrant — cholestyramine,  rather than fiber can help to  protect intestinal cells from 
exposure to bile acids.19 In addition, during the recycling of bile acids, some toxic 
compounds may attach to bile acids and be transferred to the liver together.20 Binding bile 
acids can reduce the absorption of toxic compounds into the liver and have a detoxification 
function. 
       In summary, binding bile acids can potentially lower cholesterol levels, prevent colon 
cancer, protect the liver, and control bile acid diarrhea. 
 
Selected Vegetables 
              Various vegetables have many health benefits, with anti-cancer, anti-aging, and anti-
inflammatory effects. There is high amount  of dietary fiber in red cabbage, red kale, 
Brussels sprouts, red leaf lettuce, and green kale, which helps to reduce plasma cholesterol 
 5 
 
 
levels through  binding bile acids.5 There are glucosinolates, anthocyanins, and some 
polyphenols in red cabbage and red leaf lettuce, including hydroxycinnamic acids, 
chlorogenic acid, caffeic acid, and dicaffeoyltartaric acid.6 Green kale and red kale have 
antioxidants, minerals, lutein, and vitamin C.21 The glucosinolates in Brussels sprouts 
promote the activity of phase II enzymes, and can prevent cancer.7 Among these vegetables, 
kale has become the most popular and has been embraced by consumers. It has the highest 
antioxidant activity (85.79%) in 1,1-diphenyl-2-picryl-hydrazyl (DPPH) scavenging analysis, 
much higher than white cabbage, Chinese cabbage, and choy sum.11 This suggests that kale 
can rapidly quench peroxides in the human body, which means kale can relieve oxidative 
stress before it causes damage to the human body. The main antioxidants in kale are 
kaempferol derivatives, quercetin derivatives, and some sinapoyl derivatives. For example, 
kale has kaempferol-3-O-sophoroside, kaempferol-3-(feruloyl)-sophoroside-7-diglucoside, 
quercetin-3-glucoside-7-O-glucoside, quercetin-3-sinapyl-diglucoside-7-diglucoside, 
disinapoyl-diglucoside, and sinapoyl-2-feruloyl-diglucoside. 22 Therefore, studying these 
polyphenols in kale can help us understand its potential health benefits. 
       Quercetin has an inhibitory effect on proliferation of lung cancer cells and colon cancer 
cells, and can induce apoptosis.23, 24 Quercetin induces apoptosis in colon cancer cells by 
inhibiting the NF-κB pathway,23 and it shows an antiproliferative effect on lung cancer by 
inhibiting the expression of the Bcl-2 gene and promoting the expression of Bax, since Bcl-2 
inhibits apoptosis and Bax induces apoptosis; in this way, quercetin increases the ratio of 
Bax/Bcl-2 protein, and consequently inhibit the growth of lung cancer cells.24 Kaempferol, as 
a phytoestrogen, can supress ovarian cancer development by repressing the (ERK)-NF-Κb-
cMyc-p21-VEG pathway.25 It can also reduce breast cancer cell proliferation by regulating 
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the p53 tumor suppressor gene.26 Kaempferol suppressed metastasis in osteosarcoma cells 
through interference with the ERK-p38-JNK and AP-1 signaling pathways.27 In addition, 
kaempferol have a protective function against  skin cancer by suppressing the expression of 
cyclooxygenase-2 (COX-2), which is induced by ultraviolet B light.28 Sinapoyl derivatives 
have less antioxidant activity than sinapic acid, but still demonstrate high activity (IC50=500 
µM) in DPPH scavenging assays.29  
 
Interaction Between Bile Acids and Dietary Fiber in the Vegetable 
              Since green kale is a good source for kaempferol, quercetin and dietary fiber. It 
contains 3.6% dietary fiber21, which is higher than red cabbage, red leaf lettuce and Brussels 
sprouts. Kaempferol and quercetin derivatives in kale have outstanding antioxidant activity11, 
it was chosen for the study of interactions with bile acids.  Dietary fiber in kale is associated 
with health benefit of reducing plasma cholesterol contents. 30 Kahlon’s research 
demonstrated that kale has good in vitro bile acid binding capacity.5 These studies also found 
that steamed cooked kale has higher in vitro bile acid binding capacity than uncooked kale.31 
This could be because dietary fiber or proteins changed in structure during cooking. Kahlon 
compared the in vitro bile acid binding capacity and dietary fiber contents of different 
vegetables, including green collards, kale, okra, spinach, beets, mustard greens, broccoli, 
green bell peppers, cabbage, asparagus, eggplant, turnips, green beans, carrots, and 
cauliflower, and found no direct relationship between bile acid binding capacity and total 
dietary fiber content in vegetables.13, 31 Hence it is possible that dietary fiber may not be the 
only substance in the vegetable that binds bile acids.  
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Interaction Between Bile Acids and Polyphenols in the Vegetable 
              Besides dietary fiber, bile acids also interact with other compounds. Lipid-soluble 
nutrients, such as carotene, lycopene, and lutein, require bile acids for absorption. People 
with a bile acid deficiency may have lower absorption of lipid-soluble nutrients, which would 
contribute to a deficiency of vitamin D.19 Besides carotenoids and vitamin D, phenolic 
compounds in vegetables may also interact with bile acids. Han’s research indicated that 
dietary polyphenols, curcumin, caffeic acid, rutin and ellagic acid, are able to decrease the 
toxic bile acids (deoxycholic and lithocholic acids) in feces, probably because the 
polyphenols can suppress the biosynthesis of bile acids from cholesterol together with 
cholesterol biosynthesis.32 Kale has abundant kaempferol derivatives, quercetin derivatives, 
and sinapic acid derivatives,33  and it is possible that these polyphenols may enhance the bile 
acid binding by dietary fibers in kale.  
       Even if polyphenols do not bind bile acids, bile acids in the digestive process may affect 
the releasing of polyphenols in the gastrointestinal tract. Nutrients that can release from the 
food matrix into the gastrointestinal tract are called bioaccessible nutrients. Bioaccessibility 
is a precondition of bioavailability. Bioavailable nutrients can be released from the food 
matrix during digestion, enter the gastric intestinal tract,34 enter the bloodstream, reach a 
specific location in the human body,  become available at the site of action, and have a 
physiological function. The main phenolic compounds in kale, kaempferol and quercetin, 
have excellent antioxidant capacity, which may slow down the aging process and suppress 
cancer. However, the bioavailability of kaempferol is very low, only 2%,35 and the 
bioavailability of quercetin is 4%36. Yet, even though bioavailability of kaempferol and 
quercetin are low, they can still have a protective function against cancer. For instance, 
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antioxidants with higher bioavailability may not be helpful, but bioaccessible kaempferol and 
quercetin can fight against colon cancer. Because colon cancer cells occur in the 
gastrointestinal tract, cells exposed to these antioxidants may be affected and their 
proliferation inhibited. 23, 37  Therefore, studying the bioaccessibility of phytochemicals will 
provide practical information in cancer prevention. According to our best knowledge, little 
research has been done on the effect of bile acids on polyphenol bioaccessibility. 
       This research is designed to study the in vitro bile acid binding capacity of green kale, 
red cabbage, red leaf lettuce, red kale, and Brussels sprouts. Green kale was used to identify 
the optimum dose for in vitro bile acid binding. Also, green kale was processed by 
microwave cooking and steaming and its in vitro bile acid binding capacity after cooking was 
studied. The bioaccessibility of polyphenols in kale was also compared through in vitro 
digestions with and without bile acids. 
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CHAPTER III 
 IN VITRO BILE ACIDS BINDING CAPACITIES OF DIFFERENT VEGETABLES  
 
        Dietary fiber can bind bile acids thereby lowering the reabsorption of bile acids.  This 
promotes the utilization of cholesterol to synthesize new bile acids, which can help to reduce 
plasma cholesterol levels. Secondary bile acids are also associated with colon cancer; 
therefore, reducing the free secondary bile acids can limit the risk of developing cancer. The 
present study describes the in vitro bile acid binding capacity of red leaf lettuce (Lactuca 
sativa) and the cruciferous vegetables red cabbage, red kale, green kale, and Brussels sprouts 
(Brassica oleracea). Green kale had the highest bile acid binding and we used this kale to 
determine the optimal dose to reach maximal bile acid binding capacity. The bound 
individual bile acids were quantified by reversed-phase HPLC. Further, we tested three 
different bile acid compositions that simulate various human health conditions (male with 
gallstones, healthy female, and male with type 2 diabetes). To predict the optimal dose for 
the best bile acid binding for each condition, we established the logistic relationship between 
different kale doses and bile acid binding capacities. The results indicated that kale has the 
highest bile acid binding capacity and it shows no significant difference in binding the bile 
acid compositions that mimic a healthy female and a male with gallstones, but it binds less 
bile acids from the profile of the type 2 diabetic male. Furthermore, the maximum amount 
(81.8%) of total bile acids was bound by green kale (1.8 g per 72.06 mg bile acids), and this 
remained the same up to 2.5 g. After understanding the dose-response using dried vegetables, 
we found that minimally processed (steamed) fresh kale bound even more bile acids. Among 
the six bile acids tested, kale preferentially bound the hydrophobic bile acids, 
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chenodeoxycholic acid and deoxycholic acid. Therefore, regular consumption of steam-
cooked kale has the potential to improve human health by binding more bile acids. 
 
Introduction 
      Bile acids are a group of amphipathic molecules that function as emulsifiers to assist in 
digestion and absorption of lipids in the gastrointestinal tract.  Cholesterol can  biosynthesize 
bile acids, which include cholic acid (CA), chenodeoxycholic acid, lithocholic acid (LCA), 
deoxycholic acid (DCA), glycochenodeoxycholic acid (GCDCA), glycocholic acid (GCA), 
and glycodeoxycholic acid (GDCA).1 The two primary bile acids, cholic acid and 
chenodeoxycholic acid, are synthesized by the liver, stored in the gallbladder, and then 
secreted into the small intestine, when food is being digested.2 Human intestinal bacteria can 
convert cholic acid and chenodeoxycholic acid to secondary bile acids such as deoxycholic 
acid and lithocholic acid though dehydroxylation. After assisting in lipid digestion, bile acids 
are reabsorbed through the ileum and transferred back to the liver. Up to 95% of bile acids 
are reabsorbed,1, 2 which limits the synthesis of new bile acids from cholesterol. Some bile 
acids reach the colon, where gut bacteria form more deoxycholic acid and lithocholic acid.1 
Lithocholic acid, deoxycholic acid, and chenodeoxycholic acid are hydrophobic bile acids, 
which are considered more toxic to the liver and colon cells, and may promote colon cancer.4, 
38, 39 However, dietary fiber increases the excretion of bile acids in the stool,40 which can 
potentially suppress colon cancer and lower the cholesterol level.41 Hence, binding bile acids 
can reduce intestinal cancer and reduce plasma cholesterol levels. 42, 43  
      When hydrophobic bile acids are conjugated with taurine or glycine, they become more 
hydrophilic and much less toxic to hepatic and intestinal cells.44 Some conjugated bile acids, 
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such as tauroursodeoxycholic acid, can even stabilize hepatocyte membranes and enhance the 
defense against oxidative stress, thus protecting the liver.3 Bile acid sequestrants prevent bile 
acid absorption and promote synthesis of primary bile acids from cholesterol, which leads to 
a reduction of serum cholesterol.45 Some foods can function like bile acids sequestrants; for 
instance, guar gum can reduce the concentration of serum bile acids by binding them in the 
gastrointestinal tract, which relieves the symptoms associated with intrahepatic cholestasis of 
pregnancy,46 and reduces plasma cholesterol levels.47  
       Beyond their functions of digestive emulsification and reduction of cholesterol, bile 
acids are also associated with glucose metabolism. Because bile acids can activate farnesoid 
X receptor and G-protein coupled bile acid receptor 1, which are involved in glucose 
metabolism, the control of bile acid absorption can be used as a new therapy for some 
metabolic diseases, such as type 2 diabetes.2, 46 In fact, one of the bile acid sequestrants, 
colesevelam hydrochloride, was approved by the FDA in 2008 as a medicine for the 
treatment of type-2 diabetes.48 In addition, bile acid binding has recently emerged as a 
supporting approach to strengthen the standard treatments to control plasma glucose in type-2 
diabetic patients.49 Several studies suggested that bile acids sequestrants reduced the fasting 
plasma glucose level in type-2 diabetes patients.49-52 Therefore, a vegetable with good bile 
acid binding capacity may also lower the plasma glucose level of type-2 diabetic patients.  
       Previous studies have examined the bile acid binding capacities of various vegetables, 
but few studies have examined the binding preferences for individual bile acids by specific 
vegetables.5 According to the previous research, collard greens, kale, mustard greens, 
broccoli, Brussels sprouts, spinach, green bell peppers, and cabbage have good bile acid 
binding capacity. 5 However, whether hydrophobic or hydrophilic bile acids are 
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preferentially bound by the vegetables has yet to be tested. Whether the different 
compositions of bile acid mixtures can influence the in vitro binding capacity also remains 
unknown. This study compared the in vitro bile acid binding capacities of different 
vegetables, including red cabbage, red leaf lettuce, Brussels sprouts, red kale, and green kale. 
The most active vegetable was used to test different bile acid compositions and optimal doses 
for bile acid binding.  
 
Materials and Methods 
 
Materials  
       Fresh green kale, red cabbage, red kale, Brussels sprouts, and red leaf lettuce were 
purchased from a local market. All vegetables were cut into small pieces, lyophilized and 
powdered prior to use in this study. 
 
 Chemicals  
       Sodium glycocholate, sodium cholate, sodium glycochenodeoxycholate, sodium 
glycodeoxycholate, sodium chenodeoxycholate, sodium deoxycholate, ammonium nitrate, 
potassium dihydrogen phosphate, potassium chloride, potassium citrate, uric acid sodium 
salt, urea, lactic acid sodium salt, porcine gastric mucin, α-amylase, pepsin, and pancreatin 
were obtained from Sigma-Aldrich Co (St. Louis, MO, USA). 
  
Screening of Different Vegetables for Bile Acid Binding Ability   
       The in vitro digestion was performed to mimic digestion in the mouth, stomach, and 
small intestine (Fig. 1). A simulated saliva fluid (SSF) was prepared by dissolving the 
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reagents (Table S1) in pH 6.8 phosphate buffer.53, 54 In the oral digestion phase, 2.0 g 
lyophilized vegetable was mixed with an equal weight of water and 10 ml of the SSF 
containing 0.31 mg α-amylase. The samples were vortexed and then placed in a shaking 
water bath (37°C and 180 rpm) for 5 mins. During the gastric digestion phase, the mixture 
from the oral digestion phase was adjusted to pH 2.0 with 1 N HCl, followed by the addition 
of 600 µl pepsin buffer (200 µg pepsin in 1 ml 0.1 M HCl) vortexing and incubation in a 
shaking water bath (37°C and 180 rpm) for 1 hour. For the intestinal phase, chyme from the 
gastric digestion phase was first adjusted to pH 6.8 with 1 N NaOH. The sample was then 
mixed with 5 ml pancreatin (6.25 mg/ml in 50 mM phosphate buffer), 4 ml bile acid mixture 
solution prior to incubation in a shaking water bath (37°C and 180 rpm) for 3 h.53-56 The bile 
acid mixture contained 10 mM cholate, 10 mM deoxycholate, 10 mM 
glycochenodeoxycholate, 10 mM glycocholate, and 10 mM chenodeoxycholate in potassium 
phosphate buffer (pH 6.8).  After incubation with the bile acids, the in vitro digestion was 
terminated by inactivating enzymes in a 78°C water bath for 7 min. The analyses were 
conducted using triplicate samples of freeze dried red cabbage, red kale, green kale, red leaf 
lettuce, and Brussels sprouts (2.0 g each). Digestion chymes were centrifuged at 3600 rpm 
and supernatants were collected and filtered through Whatman 90 mm filter paper. The 
residue was washed with 20 ml of nanopure water by mixing on a shaking water bath for 3 h 
and centrifuged at 800 g. Both the supernatants were filtered, combined, and concentrated 
under vacuum by rotary evaporation at 40°C to obtain 7 ml, and passed through 0.45 µm 
cellulose filters for HPLC analysis. 
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Figure 1. Schematic representation of measurement of in vitro bile acid binding capacity of 
different vegetables, and extraction of bound bile acids  
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In vitro Digestion of Different Bile Acid Compositions   
       Bile acid composition differs among individuals depending on their health condition 
and gender. To examine whether the binding capacity is influenced by the composition of the 
bile acid mixture, various bile acid compositions were used in the experiment to mimic that 
of male patients with gallstones (BAC-1), healthy females (BAC-2), and males with type 2 
diabetes (BAC-3).57, 58 Mixtures with three different bile acid compositions (BAC) were 
prepared as shown in Table S2. The BAC-1 bile acid mixture contained 33.3% cholic acid 
together with glycocholic acid, 24.9% deoxycholic acid together with glycodeoxycholic acid, 
and 41.8% chenodeoxycholic acid together with chenodeoxycholic acid. The BAC-2 mixture 
contained 33.1% cholic acid in both conjugated and unconjugated form, 17% deoxycholic 
acid and its glycine conjugated form, and 49.9% chenodeoxycholic acid together with 
glycochenodeoxycholic acid. The BAC-3 mixture contained 33.3% cholic acid (conjugated 
and unconjugated), 39.3% deoxycholic acid (conjugated and unconjugated), and 27.4% 
chenodeoxycholic acid (conjugated and unconjugated).  Lyophilized green kale was used in 
the previously described in vitro digestion protocol and during the intestinal digestion phase, 
4 ml of the three bile acid mixtures with different compositions were used. Except the bile 
acid mixtures, other parts of the in vitro experiment were the same as shown in Figure 1. 
After in vitro digestion, the supernatant was concentrated by rotary evaporation and filtered 
through a cellulose filter for HPLC analysis.  
         
Impact of Different Kale Parts on in vitro Bile Acid Binding Capacity   
       Lyophilized kale stem, kale leaf, and whole kale were tested for in vitro bile acid binding 
capacity, according to the above protocol except during the intestinal digestion phase, the 
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bile acid mixture contained taurocholate (4.84 mM), cholate (13.9 mM) and deoxycholate 
(6.16 mM). After the in vitro digestion, the supernatant was concentrated to achieve the 
minimal volume under vacuum, and passed through a cellulose filter prior to HPLC analysis.  
           
Optimization of Different Doses of Kale for Bile Acid Binding  
        Kale was found to have the highest bile acid binding capacity among the tested 
vegetables. To determine the minimal kale dose needed to bind the maximum amount of bile 
acids, different weights of kale (0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0, 2.5 g) were in another in 
vitro experiment. For this experiment, in the intestinal digestion phase, the bile acid mixture 
BAC-3 was used to mimic the bile acid profile of a diabetic male. All other procedures were 
the same as those described before.  
 
Minimal Processing of Green Kale for Bile Acid Binding  
       To understand the impact of mild processing on kale bile acid binding ability, two 
minimal processing techniques were used: 
a). Microwave processing. Fresh-cut kale (18.3 g equivalent to 2.0 g of dried sample) was 
weighed into three 150 ml beakers and 20 ml of water was added to the vegetables and 
microwaved for 1, 2, and 3 min respectively prior to the experiment. All samples were 
processed in triplicate, then homogenized to a paste for 2–3 min.  
 b). Steaming. Fresh-cut kale (18.3 g) was placed in a 150-ml beaker and steaming was 
performed for 8 and 10 min at 95°C using a water bath. Analysis of both the time points were 
conducted in triplicate and used to test the bile acid binding capacity of the homogenized 
cooked kale. 
 17 
 
 
  
Extraction of Bound Bile Acids  
       Digested residue kale (2.0 g) from section 2.6, was extracted with methanol:water:formic 
acid (80:19:1), followed by 2 min homogenization, 2 h sonication at 60°C, centrifuged for 30 
min and filtered through Whatman filter paper. The residue was re-extracted with the same 
solvent, using 10 ml of solvent as mentioned above, and combined and concentrated by 
rotary evaporation at 40°C under reduced pressure to obtain 5–10 ml and analyzed by HPLC. 
 
Quantification of Bile Acids by HPLC  
       The HPLC system consisted of an Agilent HPLC 1200 series (Foster City, CA) with a 
degasser, quaternary pump, auto-sampler, column oven, and photodiode array detector. 
Elution of bile acids was carried out with gradient mobile phases of (A) 0.3 M phosphoric 
acid in water and (B) acetonitrile with a flow rate of 0.8 ml/min at 30C using Gemini C18 
(Phenomenex, Torrance, CA) column. Bile acids were separated using the gradient, 75% to 
45% A from 0 to 10 min, 45% to 10% in 10–20 min, 10% to 75% in 20–25 min, maintained 
isocratic flow for 5 min. Data were processed using the CHEM-STATION software (Agilent, 
Foster City, CA). All six bile acids at different concentrations were injected to obtain the 
area. The calibration graphs were prepared by area versus different concentration (31.25 to 
1000 ppm) of bile acids and regression equations are presented in Table 1. Bound bile acids 
samples were injected and the presence of bile acids in each sample was examined by 
comparing the retention times with those of the standard bile acids. This assay was conducted 
in triplicate with three independent experiments and results were averaged.   
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Table 1.  Calibration curves used for quantification of bound bile acids  
 
 Bile acid Equation Dose (mg) R2 
Glycocholate y = 83017x + 52.71 2.42 0.99 
Cholate y = 9990.8x + 3.15 22.72 0.99 
Glycochenodeoxycholate y = 77178x + 31.06 9.68 0.99 
Glycodeoxycholate y = 73395x + 25.22 4.84 0.99 
Chenodeoxycholate y = 12607x - 22.76 9.68 0.99 
Deoxycholate y = 11559x + 3.77 22.72 0.99 
Taurocholate y=21149x+23.42 12.76 0.99 
 
 
Identification of Bile Acids by LC-MS  
       Bile acids were identified by ultra-high-performance liquid chromatography time of 
flight-mass spectrometry (LC QTOF–MS) (Maxis Impact, Bruker Daltonics, Billerica, MA). 
Bound bile acid samples were separated on a Zorbax Eclipse Plus C18 rapid resolution 
column (1.8 microns partial size, 100 × 2.1 mm) using an Agilent 1290 UHPLC instrument 
(Agilent, Waldbronn, Germany). The separation was carried out at 65C with a flow rate of 
0.2 ml/min using gradient elution with increasing strength of acetonitrile in 0.1% formic acid. 
Mass spectral analyses were performed using ESI-Q-TOF mass spectrometer equipped with 
an electrospray ionization source in positive ion mode. Capillary voltage was maintained at 
2.9 kV, source temperature was set at 65C and nitrogen was used as the desolvation gas (12 
l/min).  
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Fiber Analysis 
       Lyophilized green kale, red kale, red cabbage, red leaf lettuce, and Brussels sprouts were 
analyzed for total dietary fiber, soluble fiber, and insoluble fiber according to AOAC 
protocols by Medallion labs, Minneapolis. 
 
Statistical Analysis  
       All results were expressed as means ± SE. The data were evaluated by JMP Pro 12 and 
probability of p <0.05 was considered as statistically significant. Triplicate analyses were 
conducted for each sample. 
 
Results and Discussion 
Bile Acid Binding Capacities of Leafy Vegetables 
Binding bile acids has multiple health benefits.5, 54, 56 Although some vegetables have 
been tested for in vitro bile acid binding capacity, we lack comprehensive data on bile acid 
binding with reference to dose and levels of individual bile acids typical of different health 
conditions. The present study compared the bile acid binding capacities of different 
vegetables and used the vegetable with the best bile acid binding to test its effectiveness 
using various compositions of bile acids and the different doses. Figure 2 shows that the 
green and red kale exhibited the highest bile acid binding capacity, 87% and 90%, 
respectively. Among the five tested bile acids, only cholic acid showed the lowest binding 
capacity by kale. The rest of the vegetables, such as red leaf lettuce (78%) exhibited 
significantly higher binding than Brussels sprout (62%) and red cabbage (58%). Deoxycholic 
acid and chenodeoxycholic acid are the more hydrophobic bile acids, and may induce colon 
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cancer and liver stress,59, 60 but cholic acid is more hydrophilic and its liver toxicity is milder 
than that of the hydrophobic bile acids. The bile acid binding capacities of five vegetables 
were, from the highest to the lowest: red kale, green kale, red leaf lettuce, Brussels sprouts, 
and red cabbage. Table S3 shows the moisture content and fresh weight equivalent of the 
vegetables used for the bile acid binding assay. The difference in bile acid binding between 
various green vegetables may be due to their different chemical compositions, including 
phenolics, glucosinolates, flavonoids, dietary fiber, and other primary metabolites. The 
moisture content in Brussels sprouts and red leaf lettuce was the lowest (84.4%) and highest 
(95.6%), respectively. To get the bile acid binding capacity shown in this in vitro experiment, 
it required 15.7 g red kale, 15.4 g green kale, 45.9 g red leaf lettuce, 12.8 g Brussels sprouts, 
and 23.0 g red cabbage. Kale bound more chenodexoycholic acid and deoxycholic acid than 
red cabbage, Brussels sprouts and red leaf lettuce. Kale also had the highest total bile acid 
binding capacity relative to Brussels sprouts, red leaf lettuce. Although, the bile acid binding 
capacity of green kale and red kale showed no significant difference from each other, the 
literature shows that green kale has 81% more flavonols and 140% more glucosinolates than 
red kale.61 Therefore, we used green kale to determine the exact dose needed for maximum 
bile acid binding capacity. 
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Figure 2. Bile acid binding capacity of total bile acids and individual bile acids for different 
vegetables. Tested were: red cabbage, green kale, red kale, Brussels sprouts, red leaf lettuce 
and cholate (CA), glycochenodeoxycholate (GCDCA), glycodeoxycholate (GDCA), 
chenodeoxycholate (CDCA), deoxycholate (DCA). Each value is the mean taken from 3 
replicates, with error bars for the standard error. Different letters (a, b, c) indicate that the 
difference between two values is significant on the level p<0.05. 
In Vitro Digestion of Green Kale with Different Bile Acid Compositions 
       The composition of the bile acids varies among individuals, based on different health 
conditions, and is intrinsically linked to their physiology. This occurs via a variety of 
regulatory processes, difference in the ratios of primary versus secondary bile acids,  and the 
microbial ecology of the gut.62-64 To understand bile acid compositions impact on  the in vitro 
bile acid binding capacity of kale, we used three bile acids compositions to simulate different 
health conditions, including male with gallstones (BAC-1), healthy female (BAC-2) and 
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male with type-2 diabetes (BAC-3) (Table S2). The results showed that BAC-1 (male with 
gallstone) and BAC-2 (healthy female) were bound in significantly higher amounts by kale 
than BAC-3 (type-2 diabetic male model) (Figure 3). The binding capacity of deoxycholic 
acid remained the same in all three compositions. In the type-2 diabetic male model, green 
kale bound significantly less GDCA, GCDCA, GC, and left more conjugated bile acids to 
protect the liver. According to Ho et al.65 the human bile pool size is 3055 mg, and Brufau et 
al.18, 57 reported no significant difference of total bile pool size between healthy individuals 
and type-2 diabetic patients. Thus, we considered 3055 mg as the total bile acids for the 
calculation of both the healthy model and the type 2 diabetes model. 
       The U.S. Food and Drug Administration has approved a bile acid sequestrant, 
colesevelam hydrochloride, for the treatment of type-2 diabetes. Clinical trials demonstrated 
that colesvelam significantly improves the effect of three different drugs (metformin, 
sulfonylurea, and insulin) for type-2 diabetes. The addition of colesvelam involved in these 
treatments helps to reduce HbA1C from -0.32% to -0.41%.66 The mechanism by which 
colesvelam lowers blood glucose level is not yet established, however, it might be related to 
the farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5. The bile acid 
receptor FXR is involved in both lipid and glucose metabolism, and FXR can inhibit hepatic 
glucose production. Meanwhile, bile acids can induce G protein-coupled receptor TGR5, 
which can increase energy expenditure.67, 68 Therefore, green kale may provide health benefit 
to blood sugar control for type 2 diabetic patients. 
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Figure 3.  Green kale bile acid binding capacity in three different models of bile acid 
composition: male with gallstone (BAC-1), healthy female (BAC-2), type 2 male diabetic 
patients (BAC-3). Each value is the mean taken from 3 replicates, with error bars for the 
standard error. Different letters (a, b) indicates that the difference between two values is 
significant on the level p<0.05.  Each bile acid binding capacity were compared between 
different bile acid compositions.  
In Vitro Bile Acid Binding of Different Parts of Kale 
       Most of the time, kale leaf or whole kale is consumed. To understand the potential health 
benefits of kale, lyophilized kale leaf, kale stem, and whole kale were tested for in vitro bile 
acid binding. As seen in Figure 4, kale stem binds less taurocholate than kale leaf and whole 
kale, while it bound similar cholate, deoxycholate and total bile acid compared to kale leaf 
and whole kale. Additionally, whole kale bound more bile acids than kale stem and kale leaf. 
The kale stem bound  63.0% of total bile acids, including  86.3%  of deoxycholate,  56.7%  of 
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cholate and 54.8% of taurocholate. The kale leaf bound 65.2% of total bile acids with 91.4% 
of deoxycholate, 56.9% of cholate, and 58.4% of taurocholate. The whole kale sample 
bound 67.4% of total bile acids, 93.8% of deoxycholate, 59.4% of cholate and 59.4% of 
taurocholate. Therefore, it is not necessary to consume kale stems for bile acid binding, and 
whole kale has the best bile acid binding capacity. 
Figure 4.  Bile acid binding capacity of different parts of kale. Each value is the mean taken 
from 3 replicates, with error bars for the standard error. Different letters (a, b) indicates that 
the difference between two values is significant on the level p<0.05. Each bile acid binding 
capacity were compared between kale stem, kale leaf and whole kale. 
Optimization of Different Doses of Kale for Bile Acid Binding Capacity 
       To estimate the optimal dose for green kale to achieve the maximum bile acid binding 
capacity, different doses of green kale were tested in vitro. The portion of bound bile acids 
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has correlation increased with the dose of the freeze-dried green kale powder before reaching 
the saturate amount. As shown in Figure 5, the samples had limited binding capacities for 
each individual bile acid and for total bile acids. Also, each bile acid has its own optimal 
amount for the highest binding capacity; beyond this dose, even if more green kale was 
added into the in vitro digestion, the binding ratio of bile acids did not increase. Table 2 
shows the logistic regression curve explaining the relationship between kale dose and bile 
acid binding capacity, general form as Y=0.95A1. The limits for each individual and total bile 
acid binding capacity ranged from 66–94%. It is commonly stated that the threshold is the 
value of X at which the corresponding Y value is 5% below the upper plateau. Hence the 
threshold point of each logistic equation is calculated as X=A3-2.944/A2 , while Y=0.95A1, 
according to the equation derived by McDowall. 69  The threshold of each individual bile acid 
displayed in table 2 suggested that the optimal dose of kale required was 1.56 g for GCA, 
1.75 g for CA, 1.49 g for GCDCA, 1.29 g for GDCA, 1.24 g for CDCA, 0.69  g for DCA, 
and  1.31 g for total bile acids (Table 2). To compare results of kale bile acid binding 
capacity, cholestyramine resin was tested and it bound 93.45% of total bile acids at 0.33 g 
(Figure 5). 
In clinical trials of different individuals, Moutafis et al41 measured the fecal excretion 
of bile acids (1897.76 mg) in response to a dose of 30 g of cholestyramine. The logistic 
equation of this present experiment for cholestyramine is Y=98.36458/(1+exp(-
11.570799*(X+0.077039))), where Y refers to the percentage of bound bile acids and X 
refers to the dose (g) of cholestyramine. The total input of bile acids in this in 
vitro experiment is 72.06 mg, while the bile pool of the human body is 3055 mg, which is 
42.4 times the total used in this experiment. Supposing the in vitro bile acid binding capacity 
26 
can be extrapolated to the human body, 30 g of cholestyramine taken by the individual in the 
clinical trial is equivalent to 0.7075 g cholestyramine in this in vitro experiment, and 
according to the logistic regression equation obtained in this experiment, about 98.35% total 
bile acids can be bound. If this in vitro experiment can be extrapolated to the human body, 
about 3004.53 mg bile acids should be excreted into the human feces. However, Brufau et al. 
(2010)26 reported that 1897.76 mg bile acids were excreted with 30 g of cholestyramine daily 
intake, hence there is a factor linking this in vitro experiment and the clinical trial, which is 
0.6316, (1897.76/3004.53=0.6316). This in vitro experiment determined that no more than 
81.81% of total bile acids in human36 can be bound, which, adjusted by the factor 0.6316 
yields the result that 1579.98 mg bile acids can be excreted by consuming green kale. 
Extrapolated to the human body, to achieve 99% of the limit of bile acid excretion, a person 
must consume 55.6 g dry green kale, or approximately 427.0 g fresh green kale. A previous 
study reported that additional bile acid sequestrant significantly improved the reduction of 
HbA1c and LDL cholesterol by insulin-based therapy.42 Therefore, for type-2 diabetes 
patients, consuming more green kale daily may help to improve insulin-based treatment for 
control of their blood sugar. Since 427.0 g fresh green kale is not a practical dose for daily 
consumption, the widely available dried kale snacks may help increase kale intake. 
        The previously determined doses in Table 2 can be used as a reference for future in vivo 
experiments for bile acid binding and the result could vary from this in vitro experiment due 
to additional factors that involved in the digestive system. Intestinal bacteria are involved in 
the biotransformation of bile salts and may alter the bile acid composition. Certain bacteria 
could also increase the hydrophobicity of bile salts.16 For instance, Lactobacillus acidophilus 
in the human intestinal tract can deconjugate glycocholate and taurocholate, which increases 
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the CA content in the digestive tract.70 Moreover, the bile acids bound by vegetables in this 
in vitro digestion may not be permanently bound in human digestive system. In Dziedzic’s 
research, it is indicated that during large intestine digestion phase, free bile acids — cholic 
acid, deoxycholic acid and lithocholic acid — increased, compared to the small intestinal 
digestion phase. 71 Several factors may contribute to the increased bile acids in large 
intestine. One of the reason probably is due to the bacteria hydrolysis effect on dietary fibers 
and liberate the bound bile acids. Another explanation is the common faecal bacteria, E. coli, 
has cytochrome P450 enzyme, which is similar to the enzymes from hepatocytes. Therefore, 
E. coli may be able biotransform cholesterol or phytosterols to primary bile acids. 72, 73 In 
addition, human intestinal bacteria can also transform primary bile acids into secondary bile 
acids. Clostridium scindens, Clostridium hiranonis, Clostridium hylemonae, and Clostridium 
sordelli can convert DCA from CA and LCA from CDCA respectively.15, 16 
       Secondary bile acids cannot be absorbed by the liver through the portal vein and 
therefore they accumulate in the bile pool.16 Deoxycholic acid content in the bile acid pool 
can be up to 75% in some individuals favoring a Western diet.15-17 Moreover, deoxycholic 
acid can induce oxidative stress in colon cells, increase the risk of gene mutation, and 
eventually may promote the development of tumors or cancer.4 Berstein et al. (2011) 
reported that deoxycholic acid induced 94% of colon tumors in mice used in the experiment, 
including 56% of colon cancers.39 In the present study, 104.2 g of green kale was able to bind 
93.71% of the deoxycholic acid, indicating that kale consumption may have the potential to 
reduce colon cancer risk, which should be explored in future studies. 
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Table 2. Logistic regression curve for individual bile acid binding capacity in response 
to kale dose 
X: refers to green kale dose (g) 
Y: refers to bile acid binding percentage (%) 
Bile salt Equation Saturation points X value Y value 
Glycocholate 
Y=67.472958/(1+Exp(-2.2221099*(X-
 1.561  64.1 
Cholate 
0.2364677))) 
Y=70.21116/(1+Exp(-2.7243291*(X-
 1.752  66.7 
Glycochenodeoxycholate 
0.6714658))) 
Y=81.507683/(1+Exp(-3.0382878*(X-
 1.487  77.4 
Glycodeoxycholate 
0.5179148))) 
Y=81.055733 /(1+Exp(-4.011064*(X-
 1.285  77.0 
Chenodeoxycholate 
0.5510876))) 
Y=87.215157/(1+Exp(-3.6301377*(X-
 1.235  82.9 
Deoxycholate 
0.4235821))) 
Y=94.784765/(1+Exp(-7.5850513*(X-
 0.696  90.0 
Total Bile Acids 
0.3074524))) 
Y=81.883651/(1+Exp(-3.1635124*(X-
0.3817649)))  1.312  77.8 
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Figure 5. Bile acid binding capacity in response to input dose of kale leaf: (A) Glycocholate; 
(B) Cholate; (C) Glycochenodeoxycholate; (D) Glycodeoxycholate; (E) Chenodeoxycholate; 
(F) Deoxycholate; (G) Total bile acids; (H) Total bile acids binding capacity in response to 
cholestyramine dose. Bile acid binding capacity was measured as the percentage of bound 
bile acids. 
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Minimally Processed Green Kale Bile Acid Binding Capacity  
       Fresh kale (18.3 g, equivalent to 2.0 g lyophilized kale) was tested for the effects of 
minimal processing by microwaving or steaming. As shown in Figure 6, minimal processing 
significantly improved kale’s in vitro binding capacity for glycocholate, cholate, 
glycochenodeoxycholate, and glycodeoxycholate. Also, minimally cooking slightly improved 
kale’s binding capacity for chenodeoxycholate, deoxycholate, and total bile acids. However, 
the cooking methods showed no significant difference in bile acid binding. Cooked kale 
bound 90% of total bile acids. There is no significant difference in bile acid binding capacity 
between microwaved kale and steamed kale. However, 2 min’s microwave cooking bound 
slightly less glycochenodeoxycholic acid and deoxycholic acid than other cooking methods. 
Microwaved kale (2 min) bound 93% deoxycholic acid, while microwaving 1 min and 3 min 
to kale bound 97% deoxycholic acid. Steamed kale bound similar amount of total bile acids 
as microwave cooked kale. Yet, steamed kale bound significantly less chenodeoxycholic acid 
than 1 min’s and 3 min’s microwaved kale. Therefore, microwave cooking for 1 min or 3 
min can offer kale with best in vitro bile acids binding capacity. This could result from the 
changes in the structure of protein and fiber, which increases the number of active binding 
sites and thus enhances bile acid binding capacity. In addition, cooking may release some 
lipids, which promotes bile acid binding capacity. Kalhon et al5 observed similar results, but 
provided no report of binding of individual bile acids. 
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Figure 6.  Bile acids binding capacity of kale treated with different cooking methods, 
compared with lyophilized kale. Each value is the mean taken from 3 replicates, with error 
bars for the standard error. Different letters (a, b, c) indicate that the difference between two 
values is significant on the level p<0.05.  
Relationship Between Fiber Content and Bile Acid Binding Capacity 
       Total dietary fiber, soluble fiber, and insoluble fiber contents were measured (Table S3). 
The total fiber ranged between 40% and 30.3%. Each gram of insoluble fiber in these 
vegetables bound 93.1–138.7 mg of total bile acids. On comparing the bile acid binding 
capacity with fiber types, we found that soluble fiber binds more bile acids than insoluble 
fiber. Dietary fibers (pectin and gum) can swell and their surface area will increase in an 
aqueous system, which may enhance the bile acid binding capacity.74 Each gram of dietary 
fiber from red leaf lettuce binds 109.2 mg of bile acid. Therefore, among these five 
vegetables, the total bile acid binding capacity cannot be related to the total dietary fiber 
content. Kahlon et al5 reported the bile acid binding capacity using various vegetables and 
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the activity has been attributed to bioactive compounds present in each crop, along with total 
dietary fiber content and type of fibers. In the present study, total bile acid binding capacity 
based on the insoluble fiber (ISF) were red leaf lettuce, followed by red kale, green kale, 
Brussels sprouts, and red cabbage. Each gram of insoluble fiber in these vegetables bound 
93.1 to 138.7 mg of total bile acids.  
Comparison of the bile acid binding capacity based on soluble and insoluble fiber 
showed that soluble fiber binds much more bile acids than insoluble fiber. Soluble fiber 
mainly includes pectin, gum, and hemicellulose; insoluble fiber mainly includes 
hemicellulose and cellulose. Gum and pectin have good in vitro bile acid binding capacity, 
but cellulose does not bind bile acids very well.5, 47, 75 The result of individual bile acid 
binding capacity tests of dietary fiber from five vegetables indicated that 
glycochenodeoxycholic acid was bound mostly by dietary fiber.  
       
Confirmation of Bile Acids 
       To confirm the bound bile acids, the digested residue of each vegetable was extracted 
with MeOH:water:formic acid (80:19:1) and analyzed by high resolution mass spectrometry. 
Figure 7A shows the total ion chromatogram and broad band collision-induced dissociation 
(bbCID) mass spectra of five bile acids separated in 8 min. Figure 7 (B–F) shows the 
accurate mass spectra of molecular ions obtained by electrospray negative ionization mode 
for each bile acids along with their bbCID spectra. All the molecular weights matched those 
of their respective molecular ions, which confirms the presence of intact bile acids without 
degradation.  
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Figure 7. Confirmation of bile acids by LC-MS, [A]. Total ion and broadband collision-
induced dissociation (bbCID) chromatogram of bound bile acids separated on eclipse plus 
C18 column.   
[B-F]. Mass spectra of bound bile acids confirmed by high resolution time of flight by 
electrospray negative ionization mode. 
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Conclusion 
             Red kale and green kale have higher in vitro bile acid binding capacity than red 
cabbage, red leaf lettuce, and Brussels sprouts. Green kale was equally effective at binding 
bile acids, when the BA  composition simulated  a healthy female or a male with gallstone, 
and it bound slightly lower amounts of bile acids, when  the profile simulated bile acids in a 
type 2 diabetic male. In the bile acid mixture mimicking type-2 diabetic patients, green kale 
bound no more than 81.8% of the bile acids, which was accomplished by a dose of 1.31 g 
(dried weight). Converted to the human body, as much as 51.7% of bile acids can be excreted 
by consuming 55.6 g green kale (dry matter), which is about   427.0 g of fresh green kale. 
Green kale preferentially bound the hydrophobic bile acids deoxycholic acid and 
chenodeoxycholic acid. The recommended green kale dose demonstrated the ideal bile acid 
binding in the in vitro experiment; this dose can be used as a reference for future in vivo 
experiments or even clinical trials. In addition, steaming and microwave heating improved 
kale’s bile acid binding capacity. 
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CHAPTER IV 
ENHANCED BIOACCESSIBILITY OF KALE POLYPHENOLS 
BY BILE ACIDS INVOLVED IN THE IN VITRO DIGESTION 
 
       Kale has abundant dietary fiber and polyphenols, mainly derivatives of kaempferol and 
quercetin. Quercetin and kaempferol have antiproliferative activities on colon cancer cells. 
Dietary fiber can bind bile acids, but whether the polyphenols in kale contribute to its in vitro 
bile acid binding capacity remains unknown. Also, there is no established theory about how 
bile acids interact with kale’s bioactive compounds, including dietary fiber and polyphenols. 
In this study, polyphenols were separated from the fiber-rich tissue in kale (Brassica 
oleracea) through Soxhlet extraction, and then were incubated with bile acids. Raw kale was 
incubated with bile acid mixtures during in vitro digestion, and the bile acid binding capacity 
was compared with that of the fiber-rich tissue in the Soxhlet-extracted residue. Finally, 
lyophilized raw kale was digested in vitro with and without bile acids. These results indicated 
that the fiber-rich tissue in kale binds the most bile acids. Polyphenols in kale do not attach to 
bile acids after the incubation, but they may interact with bile acids through intermolecular 
interactions. Bile acids involved in the in vitro digestion can change the polyphenol profile of 
kale. Raw kale (1.0 g) contains 2.19 mg of quercetin derivatives, 0.98 mg of kaempferol 
derivatives, and a total of 3.15 mg of identified polyphenols. When bile acids were added to 
the in vitro digestion, 63.8% of total identified polyphenols were bioaccessible, 60.1% of 
quercetin derivatives were bioaccessible, and 70.2% of kaempferol derivatives were 
bioaccessible. Without bile acids in the in vitro digestion, the bioaccessibility of total 
identified polyphenols and kaempferol derivatives was 14.5% and 3.3%, respectively, but 
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only 39.1% of quercetin derivatives were bioaccessible. Therefore, bile acids can 
significantly improve the bioaccessibility of quercetin derivatives and total identified 
polyphenols, but slightly decrease the bioaccessibility of kaempferol derivatives. 
 
Introduction 
       Kale (Brassica oleracea) is a cruciferous vegetable and has won consumers’ favor for its 
antioxidant capacity, anti-cancer potential, and possible anti-aging function. It can be 
consumed in salads, soups, or roasted as a snack. Kale has a high amount of dietary fiber and 
various other nutrients, including polyphenols, carotenoids, and minerals. The excellent 
antioxidant capacity of kale results, in part, from the presence of numerous types of 
polyphenols, mainly derivatives of kaempferol and quercetin, plus some phenolic acids, such 
as caffeoylquinic acid, p-coumaroylquinic acid, and feruloylquinic acid.22 Kaempferol and 
quercetin in kale have been identified as outstanding antioxidants than can suppress cancer 
and potentially slow down the aging process.76 Quercetin can inhibit α-amylase and α-
glucosidase, which can help control blood sugar levels for  
type-2 diabetic patients.77 Kale also has some carotenoids, including β-carotene and lutein, 
which have a protective function for our eyes. 9, 10  
       Abundant valuable nutrients exist in kale, yet not all them can be absorbed. For example, 
some nutrients can be trapped in the plant cells or bound by the indigestible fiber during 
digestion. Bioaccessibility measures the fraction of a nutrient that is released from the food 
during digestion. Other nutrients can be released from the food matrix during digestion, enter 
the gastric intestinal tract,34 enter the bloodstream, reach a specific location in the human 
body, and become available at the site of action. Although some compounds may not show 
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very high bioavailability during in vivo digestion, they may still have health benefits. For 
instance, the bioavailability of kaempferol  is approximately only 2%; 35 however, the 
consumption of kaempferol improves the cytotoxicity of cisplatin, increasing its anticancer 
power. 78 79  Hence, it is possible that the anticancer property of kaempferol is more related to 
its bioaccessibility rather than its bioavailability. Since kaempferol derivatives and quercetin 
derivatives are the main polyphenols in kale,8 it is essential to study their bioaccessibilities 
and their interactions with other chemicals.  
       Besides polyphenols, kale also contains a large amount of dietary fiber, which can 
maintain a healthy intestinal microbiota and normal bowel movements. Dietary fiber is also 
considered to have a protective effect against colon cancer because it can promote the growth 
of health-beneficial microbes in the intestine and maintain the bulk and moisture of 
excretion. 80 Besides preventing colon cancer, dietary fiber can bind and sequester bile acids. 
81 Kahlon et al (2007) examined the in vitro bile acid binding capacity of various vegetables, 
including kale, broccoli, and Brussels sprouts, and found that kale displayed strong bile acid 
binding capacity.5 Interestingly, the same amount of dietary fiber from different vegetables 
showed different bile acid binding capacities. For instance, 100 mg of total dietary fiber from 
kale bound 2.27 µmol of bile acids, and 100 mg of total dietary fiber from cabbage only 
bound 0.81 µmol bile acids. 5 Therefore, other bioactive compounds, such as polyphenols or 
carotenoids, may influence the bile acid binding capacity of dietary fiber. Bile acids in the 
digestive system could also interact with polyphenols or carotenoids and affect their 
bioaccessibilities. However, the interaction between bile acids and various bioactive 
compounds in kale has not yet been studied. The present study was designed to determine the 
main bile acid binding components in kale, and examine the potential impact of bile acids on 
 38 
 
 
kale’s bioactive compounds. The bioactive compounds in kale, polyphenols and fiber, were 
separated through Soxhlet extraction, and were incubated with bile acids to determine their 
interactions. Raw kale also went through the in vitro digestion process both with and without 
bile acids, in order to study bile acids’ impact on the bioaccessibility of kale polyphenols. 
 
Materials and Methods  
Plant Materials and Reagents 
       Green kale was purchased from the local market, cut into half inch squares, frozen at -
18°C and lyophilized.  
       Hexane, acetone, and methanol were used for extraction. LC-MS grade methanol, water, 
and acetonitrile were used for analytical work. All the solvents were purchased from Sigma-
Aldrich Co. (St. Louis, MO, USA).  
 
Extraction of Phytochemicals from Kale 
       The lyophilized kale sample (2.0 g) was added to 35 ml extraction solution MeOH : 
water : formic acid (80:19:1), followed by 2 min of homogenization and 2 h of sonication at 
70°C. The extract was centrifuged (BeckMan Model TJ-6), filtered and the residue was re-
extracted with 20 ml of the same solvent as previously used. Both extracts were pooled, 
filtered through Whatman filter paper, and concentrated under vacuum using a rotary 
evaporator (Buchi) to obtain a sample of around 10 ml, which was then filtered through a 
cotton cartridge filter for further LC-MS analysis. 
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Soxhlet Extraction from Raw Kale for Bile Acid Binding Ability 
       Lyophilized kale (209 g) was loaded into the Soxhlet type apparatus and extracted with 
hexane (2 l) at boiling temperature for 48 h for the removal of fatty material. The residue was 
reextracted successively with acetone and MeOH: water: formic acid (80:19:1) separately for 
48 h each.  All the extracts were filtered and concentrated separately with a vacuum 
evaporation apparatus to obtain the minimal volume and remove traces of solvents, and 
lyophilized to obtain dried extract. The yields of hexane, acetone, and MeOH: water: formic 
acid (80:19:1) extracts were 7.17 g, 6.36 g, and 39.34 g, respectively. The  MeOH:  water: 
formic acid fraction was dissolved in water with 1% formic acid and 5% acetone, to 5000 
ppm. All the extracted fractions were used for further LC-MS analysis. The leftover kale 
residue (fiber-rich tissue) was removed from the Soxhlet extraction apparatus, air dried, and 
used for bile acid binding capacity assays.  
       The digestion process involved simulated oral digestion, gastric digestion, and small 
intestinal digestion. For the oral digestion, simulated saliva fluid (SSF) components (see 
Table S1) were dissolved in phosphate buffer (pH 6.8). Soxhlet-extracted solvent extracts 
(0.1 g) were mixed with 0.1 ml of DMSO and 1 ml simulated saliva fluid and vortexed, 
followed by water bath shaking at 37°C for 5 min, at 180 rpm. For gastric digestion, the 
chyme pH was adjusted to 2.0 with 1 N HCl, then 60 µl pepsin buffer (200 µg pepsin in 1 ml 
0.1 M HCl) was added to each sample, followed by vortexing and water bath shaking at 37°C 
for 1 h. For intestinal digestion, the chyme pH was adjusted to 6.8 with 1 N NaOH, followed 
by the addition of 0.5 ml pancreatin (6.25 mg/ml in 50 mM phosphate buffer), 0.4 ml bile 
acid mixture solution (2.54 mM sodium glycodeoxycholate, 12.08 mM sodium cholate, 13.22 
mM sodium deoxycholate, 5.14 mM sodium glycochenodeoxycholate, 1.24 mM sodium 
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glycocholate, 5.84 mM sodium chenodeoxycholate), then vortexing, and water bath shaking 
at 37°C for 3 h. After the incubation with bile acids, the in vitro digestion was terminated by 
inactivating enzymes at 78°C in a water bath for 7 min. The final digestion fluid was around 
2 ml for each digestion sample. 
       Analytical samples were collected after the termination of in vitro digestion. After 
inactivation of the enzyme, the digestion chyme was centrifuged at 800 g for 30 min, the 
supernatant was carefully collected and filtered through Whatman 90 mm Ø filter paper. The 
remaining residue was rinsed with 2 ml nano-pure water in a water bath, with shaking for 2 
h. 
 
In vitro bile acid binding capacity of fiber-rich kale tissue and raw kale  
       The fiber-rich kale tissue (0.71 g and 1.0 g) and raw kale (1.0 g) were used for in vitro 
digestion with bile acids. The raw kale and fiber-rich Soxhlet extracted residue samples (in 
triplicate) were suspended in water in a ratio of 1:1 and 10 ml simulated saliva fluid 
(components see Table S1), before 0.31 mg α-amylase was added to the samples and then 
mixed by vortexing for 30 s. The samples were incubated in a shaking water bath at 37°C for 
6 min, with a shaking speed of 180 rpm. Then, to stimulate gastric digestion, the chime pH 
was adjusted to 2.0 with 1 N HCl, and 600 µl pepsin (200 µg pepsin in 1 ml 0.1 M HCl) was 
added and incubated in a shaking water bath at 37°C for 1 h. Further intestinal digestion was 
conducted at pH 6.8, followed by the addition of 5 ml pancreatin (6.25 mg/ml in 50 mM 
phosphate buffer), 4 ml bile acid mixture (2.54 mM sodium glycol deoxycholate, 12.08 mM 
sodium cholate, 13.22 mM sodium deoxycholate, 5.14 mM sodium glycochenodeoxycholate, 
1.24 mM sodium glycocholate, 5.84 mM sodium chenodeoxycholate), then vortexed, and 
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incubated in a water bath, with shaking, at 37°C for 3 hrs. After the incubation with bile 
acids, the in vitro digestion was terminated by inactivating enzymes at 78°C in a water bath 
for 7 min.  The final digestion reaction was around 20 ml for each sample. 
       Analytical samples were collected after the termination of in vitro digestion. After 
inactivation of the enzyme, the digestion chyme was centrifuged at 800 g for 30 min, the 
supernatant was carefully collected and filtered through Whatman filter paper. The remaining 
residue was rinsed with 30 ml nano-pure water in water bath shaking for 2 h. The two 
supernatants were combined and rotary evaporated at 40°C to reduce the volume to 
approximately 10 ml, which was filtered through a cotton cartridge filter and used for HPLC 
analysis. 
 
Bioaccessible compounds of kale after in vitro digestion (with and without bile acids) 
       Lyophilized kale (1.0 g) was used to conduct another in vitro digestion process that 
included oral, gastric, and intestinal phases. In the oral digestion phase, 0.31 mg α-amylase 
was added into 10 ml simulated saliva fluid (SSF) with ingredients shown in Table S1, and 
rest of the digestion process followed as mentioned above. 53-56 
       For analysis of bioaccessible compounds, one set of samples was digested with 4 ml 
buffer replacing the 4 ml bile acid mixture. All samples were centrifuged, washed, pooled, 
and filtered through a cotton cartridge filter for further LC-MS analysis. The residue was 
extracted twice with 20 ml of MeOH: water: formic acid (80:19:1), with a 2 min 
homogenization followed by 2 h sonication, then centrifuged at 800 g for 30 min. Both the 
supernatants were combined and concentrated under vacuum by rotary evaporation at 40°C 
and adjusted to a known volume, then filtered through a cotton cartridge for LC-MS  
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Quantification of Bile Acids by HPLC 
       Bile acids in the samples were quantified with an Agilent 1200 Series HPLC consisting 
of a degasser, quaternary pump, auto-sampler and PDA detector at 210 nm. Samples (25 µl) 
were injected and separation was carried by reversed phase Gemini C18 column with solvent 
A (30 mM phosphoric acid) and solvent B (acetonitrile). Compounds were eluted as follows, 
75% to 45% A from 0 to 10 min, 45% to 10% from 10 to 20 min, 10% to 75% A from 20 to 
25 min, isocratic at 75% A from 25 to 30 min. Each individual bile acid was injected at 
different concentrations (1000 to 12.5 µg/ml) to obtain calibration graphs. Using the 
individual regression equations, the bound bile acids were quantified using peaks area and 
dilution factors. This assay was conducted in triplicate with three independent experiments 
and results were averaged.  
 
Fiber Analysis 
       Lyophilized raw kale and fiber-rich fractions were analyzed for total dietary fiber, 
soluble fiber, and insoluble fiber according to the Association of Analytical Communities 
protocols by Medallion Labs (Minneapolis, MN). 
 
LC-MS Analysis 
       The digested supernatants, methanol extracts from digested residues, raw kale, and 
Soxhlet extracts were analyzed by LC-MS. The chemical constituents from all the samples 
were characterized by ultra-high performance liquid chromatography-time of flight-mass 
spectrometry (UHLC-QTOF-MS) (maXis impact, Bruker Daltonics, Billerica, MA). The 
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separation was performed on Zorbax rapid resolution high definition Eclipse Plus C18 
column (2.1 mm × 100 mm, 1.8 μm particle size). Column temperature was kept at 75 ̊C with 
a flow rate of 0.2 ml/min. The mobile phases used for separation were (A) 0.1% formic acid 
in nano pure water and (B) 0.1% formic acid in acetonitrile (7:3). The column was eluted as 
follows, 100% A for 0 to 5 min, 100–98% A for 5 to 10 min, 98–55% A from 10 to 22 min, 
55–40% A from 22 to 27 min, 40–10% A from 27 to 31 min, isocratic for 31 to 34 min, 10–
100% A from 34 to 40 min. The column was equilibrated for 2 min before the next injection. 
Mass spectral analyses were performed using the quadruple time of flight (Q-TOF) mass 
spectrometer equipped with an electrospray ionization source in positive ionization mode. 
MS experiments were carried out under the following conditions, ionization source in 
positive ionization mode ESI (+); MS scan range 50–1000 m/z; end plate offset 500 V; 
capillary 3000 V, nebulizer gas (N2) 0.2 bar; dry gas (N2) 48 l/min; dry temperature: 200°C; 
ion transfer conditions funnel RF: 200 Vpp; multiple RF: 200 Vpp; quadruple low mass 55 
m/z; collision energy 5.0 eV; collision RF 600 Vpp; ion cooler RF 50–250 Vpp ramping; 
transfer time 121 μs; and pre-pulse storage time 1 ms. External mass spectrometer calibration 
was performed using a Cole Palmer syringe pump (Vernon Hills, Illinois, USA) directly 
connected to the interface, equipped with a Hamilton syringe (Reno, Nevada, USA) 
containing sodium formate (5 mM sodium hydroxide and water: 2-propanol 1:1 (v/v) with 
0.2% of formic acid). The calibration solution was injected at the end of the run and all the 
spectra were calibrated prior to the identification for obtaining accurate mass values due to 
the compensation of temperature drift in the mass analyzer. Nine sodium formate clusters 
were used in the calibration using the high-precision calibration mode. 
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       The accurate mass data for the molecular ions were processed using the software Data 
Analysis 4.3 to get the list of possible elemental formulae by using SmartFormula. CHNO 
was used as standard functionalities, including ring-plus double bonds equivalents, electron 
configuration. Comparison of the theoretical with the measured isotopic pattern was used to 
obtain mSigma for the suggested molecular formula. The accuracy threshold for most of the 
compounds is within 25 ppm. A window of ±0.005 to 0.002 m/z was used for the extracted 
ion chromatograms (EIC) to extract the exact masses. Molecular formula determination was 
carried out by combined evaluation of mass accuracy, isotopic patterns, adduct and fragment 
information using SmartFormula. Identified compounds were quantified as quercetin 
equivalents. Different concentrations of quercetin and kaempferol (100, 50, 25, 12.5, 6.25 
and 3.125 µg/ml in methanol) were injected (1 µl) into the LC-MS and regression equations 
were obtained by plotting the peak area of mass spec peak verses concentration. 
Results and Discussion 
       To explore the interaction between bile acids and bioactive compounds in kale, we first 
aimed to identify the bioactive compounds in kale, then we studied the interaction of bile 
acids with the Soxhlet-extracted fraction and residue. Finally, we examined the effect of bile 
acids on the bioaccessibility of kale polyphenols. 
Statistical Analysis  
         All results were expressed as means ± SE. The data were evaluated by JMP Pro 12, 
SPSS and probability of p <0.05 was considered as statistically significant. Triplicate 
analyses were conducted for each sample.   
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removed most phenolic components of the kale tissue, except the fiber. Lyophilized raw kale 
had 39.5% total dietary fiber, 6.6% soluble fiber and 32.9% insoluble fiber. By contrast, the 
Soxhlet-extracted kale residue had 46.6% total dietary fiber, 10.8% soluble fiber, and 35.8% 
insoluble fiber. After Soxhlet extraction, total dietary fiber increased by 18%, soluble fiber 
increased by 64%, and insoluble fiber increased by 9% (Table S4). This is due to the loss of 
compounds extracted by the solvent; 29% of the kale mass was lost during the Soxhlet 
extraction. 
       In addition, the fiber composition of the residue was changed by the extraction. The 
Soxhlet-extracted residue was 71% of the originally loaded kale, and after Soxhlet extraction, 
total dietary fiber decreased by 16.24%, water-soluble dietary fiber increased by 16.2%, and 
water-insoluble dietary fiber decreased by 22.7%. This change of soluble fiber and insoluble 
fiber content was also observed in previous research. For example, Chang’s study indicated 
that heat treatment of apple fiber, corn fiber, oat bran, and soy fiber increased the water-
soluble fiber contents and reduced insoluble fiber contents.82 During Soxhlet extraction, the 
solvent was evaporated at its boiling temperature, which is  a heat treatment to the sample 
material. This could be the reason why Soxhlet extraction produced an increase in water-
soluble dietary fiber and a decrease in water-insoluble dietary fiber. During the Soxhlet 
extraction, the insoluble dietary fiber may be converted to soluble dietary fiber if the high 
Bile Acid Binding Capacity of Solvent Extracts and Fiber-Rich Fractions from Soxhlet 
Extraction 
       After Soxhlet extraction, the total dietary fiber, soluble fiber, and insoluble fiber contents 
of the residue all were higher than in the original raw kale, as expected since the extraction 
46 
MeOH-extracted fraction, raw kale sample, and Soxhlet-extracted kale residue have similar 
binding capacities for glycocholate and cholate (See Figure 8). However, the extracted 
fraction of MeOH: water: formic acid (80:19:1) bound less glycochenodeoxycholate, 
glycodeoxycholate, chenodeoxycholate and deoxycholate than raw kale and kale residue. 
Even though the Soxhlet-extracted fraction of MeOH: water: formic acid (80:19:1) bound 
similar amounts of glycocholate and cholate as raw kale and fiber-rich kale tissue, we found 
3.15 mg/g total identified polyphenols in kale (see Section 3.4). Therefore, the polyphenols 
in kale may not contribute substantially to its bile acid binding capacity. 
       In the experiment with Soxhlet extracted kale residue, the weight of kale residue after 
Soxhlet extraction was only 71% of the original weight; therefore, we compared the bile acid 
binding capacity of 0.71 g kale residue (dry matter) and 1.0 g raw kale (dry matter). The bile 
acid binding capacity slightly declined after Soxhlet extraction.. Figure 9  compares the
bile acid binding capacity of 0.71 g kale residue and 1.0 g raw kale; the results indicated that
there  is  no  significant  difference  between  their  binding  capacities  of  total  bile  acids,  
glycocholic  acid, cholic  acid, glycochenodeoxycholic acid, chenodeoxycholic acid,  and
deoxycholic acid.  However, the 0.71 g extracted kale  residue bound more  glycodeoxycholic 
acid  than  1.0  g  raw  kale.  Comparing  the  bile  acid  binding  capacity  of 1.0 g fiber-rich 
Soxhlet extracted residue and 1.0 g  raw kale,  the  Soxhlet-extracted residue  showed  higher
temperature breaks the weak bonds between polysaccharide chains and splits glycosidic 
linkages in the dietary fiber, thus solubilizing the insoluble dietary fiber.83   
       In the experiment that tested the bile acid binding capacity of the Soxhlet-extracted 
fraction, some sediments appeared. There might be some bile acids trapped or bound by the 
sediments in the samples. Tests of in vitro bile acid binding capacity suggested that the 
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       Kale is a good source of dietary fiber84 and dietary fiber has demonstrated bile acid 
binding capacity through in vitro experiments, in vivo experiments, and clinical trials.85-87 
Two different hypotheses can explain fiber’s ability to bind bile acids. One hypothesis 
suggested that dietary fiber can physically trap bile acids through hydrophobic or hydrophilic 
interactions in the gel matrix.88 The other hypothesis suggested that bile acids can be 
chemically bound by polysaccharides or dyes, which has a steric moiety.89  
    Our results indicated that 0.71 g extracted residue and 1.0 g raw kale bound similar 
amounts of glycocholic acid, cholic acid and glycochenodeoxycholic acid. These 
observations indicate that these three bile acids might be physically trapped by the fiber-rich 
tissue in kale since the amount of fiber-rich tissue in 0.71 g extracted residue is same with 
that in 1.0 g raw kale. However, chenodeoxycholic acid may be chemically bound by soluble 
fiber, since the soluble fiber in 0.71 g Soxhlet extracted residue is 13.6% higher than that in 
1.0 g raw kale. Soluble fiber can form a gel, which increases the viscosity in the intestine, 
and has high bile acid binding capacity.90 This may be why glycodeoxycholic acid was 
bound more by 0.71 g kale residue than 1.0 g raw kale. Soluble fiber also shows better 
hypolipidemic and hypoglycemic responses, compared to insoluble fiber.90   
By contrast, glycodeoxychholic acid and deoxycholic acid may be chemically 
bound by insoluble fiber.89 The insoluble fiber in 0.71 g Soxhlet residue is 22.8% lower 
than that in 1.0 g raw kale, and 0.71 g Soxhlet residue bound significantly less deoxycholic 
acid than 1.0 g raw kale. However, the insoluble fiber in 1.0 g Soxhlet extracted residue is 
only 7.0% higher than that in 1.0 g raw kale, and the residue showed no significant binding
binding capacity for  total  bile acids,  glycocholic acid,  cholic  acid,  
glycochenodeoxycholic acid, and chenodeoxycholic acid, but similar binding capacity for 
glycodeoxycholic acid and deoxycholic acid. 
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Figure 8. Bile acid binding capacity raw kale, acetone-extracted fraction, extraction residue, 
methanol extracted fraction. Different letters (a, b, c) indicate that the difference between two 
values is significant on the level p<0.05.   
capacity to deoxycholic acid. Camire also reported that deoxycholic acid binding capacity is 
correlated with insoluble dietary fiber contents.91  
Figure 9. Bile acid binding capacity of raw kale and kale Soxhlet extraction residue. 
Different letters (a, b, c) indicate that the difference between two values is significant on the 
level p<0.05.   
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Preliminary Identification and Quantification of Bioactive Compounds in Raw Kale and 
Incubation with Bile Acids 
       The tentative identification of phenolic compounds extracted from raw kale with MeOH 
and MeOH: water: formic acid (80:19:1) is shown in Table 3, which provides information on 
retention times, protonated molecules, and major fragment ions. Peak identification was 
conducted based on the data in Table 3, comparing with the compounds in kale from a 
previously published paper and the standard molecular weights.22, 33 Compounds from the 
raw kale include derivatives of kaempferol and quercetin, together with caffeoylquinic acid 
and sinapoyl derivatives. The UV spectra of various compounds were recorded with a Diode 
Array Detector (DAD), which indicated that kaempferol derivatives and quercetin derivatives 
are the main polyphenols presented in kale. Their exact molecular weights cannot be 
established from LC-MS analysis directly. However, by comparing the molecular ions and 
fragments obtained with an ESI-MS-MS detector (See Table 3), the compounds were 
tentatively identified.  
       We identified nineteen phenolic compounds in the MeOH-extracted fraction, and 
twenty-seven phenolic compounds in the MeOH: water: formic acid (80:19:1)-extracted 
fraction. Among these phenolics, we found nine compounds in both the MeOH-extracted and 
MeOH: water:formic acid (80:19:1)-extracted fractions, including caffeoylquinic acid, three 
quercetin derivatives, and five kaempferol derivatives. Among the nineteen compounds in 
the MeOH-extracted fraction, we found seven quercetin derivatives, eleven kaempferol 
derivatives, and caffeoylquinic acid. The MeOH: water: formic acid-extracted fraction 
contained nine quercetin derivatives, thirteen kaempferol derivatives, four sinapoyl 
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derivatives, and caffeoylquinic acid. The kaempferol derivatives are caffeoyl, sinapoyl, 
feruloyl and hydroxy feruloyl, 3,7-glucosides, diglucoside. The quercetin derivatives are 
feruloyl, 3,7-glucoside, diglucoside, and triglucoside. The pseudomolecular ions recorded 
with the HPLC-ESI MS and the fragments obtained confirmed these structures with the 
characteristic losses of a glucoside, a diglucoside, sinapoyl, caffeoyl and feruloyl residue 
respectively, leading to the kaempferol aglycone fragment at m/z 287. The high-resolution 
mass spectrometry analysis confirmed these structures (Table 3). 
       Kaempferol was used as the molar equivalent to quantify its derivatives, and quercetin 
was used as the molar equivalent to quantify quercetin derivatives. The results show that 
quercetin-3-sinapoyl-diglucoside-7-triglucoside is the most abundant phenolic compound 
extracted from kale in this method, followed by kaempferol-3-(feruloyl)-sophoroside-7-
diglucoside, quercetin-3-O-(feruloyl)-sophoroside-7-O-diglucoside, kaempferol-3-sinapoyl-
diglucoside-7-O-diglucoside, and quercetin-3-sophoroside-7-glucoside. These are the major 
polyphenols extracted from green kale in this experiment. Each gram of dry matter kale 
contained 0.46 mg quercetin-3-sophoroside-7-sophoroside, 0.31 mg quercetin-3-sinapoyl-
diglucoside-7-diglucoside, 0.47 mg quercetin-3-sinapyl-diglucoside-7-diglucoside, 0.37 mg 
quercetin-3-O-(feruloyl)sophoroside-7-O-digulcoside. 
       The present research found similar compounds to those reported by Ferioli among the 
polyphenols in kale, such as caffeoylquinic acid, disinapoyl-diglucoside, sinapoyl-feruloyl-
diglucoside, trisinapoyl-diglucoside, disinapoyl-feruloyl-gentiobiose.22 Lin’s study showed 
most of the kaempferol derivatives and quercetin derivatives were the same as in this study.33 
Both kaempferol and quercetin have strong antioxidant capacities92 and quercetin shows an 
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inhibitory effect on α-amylase activity, which can help to control blood sugar level in type 2 
diabetic patients.93 The literature indicated that kaempferol and quercetin synergistically 
inhibit the growth of human intestinal cancer cells.94 In addition, kale binds bile acids  and 
leaves less bile acid remained for the activation to farnesoid X receptor and G-protein 
coupled bile acid receptor 1, which are also involved in glucose metabolism, and 
consequently control blood sugar level in type-2 diabetic patients. Therefore, kale can 
provide the health benefits of slowing down the ageing process, improving blood sugar 
control in type-2 diabetic patients, and suppressing intestinal cancer. 
       The Soxhlet-extracted fraction from raw kale was incubated with bile acids, then 
analyzed by LC-MS (Table 4). Comparing Table 4 and Table 3 shows that after incubation 
with bile acids, the polyphenols extracted from kale did not attach to any bile acid to form a 
new molecule. However, some new polyphenols appeared after incubation with bile acids. 
These new polyphenols are disinapoyl-diglucoside, 1-sinapoyl-2-feruloyl-diglucoside, 1-
sinapoyl-2-feruloyl-gentiobiose, and disinapoyl-feruloyl-gentiobiose. Meanwhile, all six bile 
acids put into the incubation (glycoholic acid, cholic acid, glycochenodeoxycholic acid, 
glycodeoxycholic acid, chenodeoxycholic acid, and deoxycholic acid) are still found in the 
liquid after incubation. Also, we did not find any new molecules formed from the polyphenol 
attached to the bile acids, which suggested that polyphenols in kale do not contribute to 
kale’s bile acid binding capacity in this in vitro experiment. However, Ogawa (2015) 
reported that some polyphenols, such as catechins and oolongtheanins from tea, can interact 
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with taurocholic acid and reduce the solubility of phosphatidylcholine (PC) and cholesterol in 
micelles.95 Ogawa used nuclear magnetic resonance to show that tea polyphenols and bile 
acids are in close proximity. Yet the polyphenols and bile acid did not form a new molecule 
but interacted with each other through hydrogen bonding. This intermolecular force changed 
the structure of bile acid cholesterol micelles and lowered its solubility. Therefore, according 
to Ogawa’s theory, even though we did not find new molecular forms after incubation of the 
bile acids with kale polyphenols, it is still possible that polyphenols in kale may interact with 
bile acids, alter the solubility of bile acids, and influence their reabsorption in the 
enterohepatic circulation. 
Preliminary Identification and Quantification of Bioactive Compounds in Kale of in vitro 
Digestion 
       After the in vitro digestion (with or without bile acid incubation in small intestine 
digestion phase), part of these polyphenols existed in raw kale was released into the digestion 
supernatant, which means they were accessible and eventually could be absorbed by our 
bodies. Part of the polyphenols remains in the digested residue, indicating that they are not 
bioaccessible. Table 5 showsthe bioaccessible and non-bioaccessible compounds in digested 
kale samples, both with and without bile acids. Without bile acids incubation, there are eight 
compounds released into digestion supernatant, which means they are bioaccessible without 
bile acids involved in the digestion. Fifteen compounds are found in the digestion residue, 
when there is no bile acid in the digestive process.With bile acids involved in the in vitro 
digestion, there are twenty-one compounds in the supernatant and sixteen polyphenols in the 
digested residue. Some compounds are not bioaccessible both with and without bile acids 
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involved in the digestion process, such as caffeoylquinic acid, kaempferol-3-
hydroxyferuloyl-diglucoside-7-O-diglucoside, kaempferol-3-hydroxyferuloyl-diglucoside-7-
O-glucoside, kaempferol-3-O-(sinapoyl)-glucoside-7-O-glucoside, kaempferol-3-O-
(sinapoyl)-sophoroside-7-glucoside, kaempferol-3-O-(sinapoyl)-sophorotriose, quercetin-3-
O-(feruloyl)-sophoroside, 1-sinapoyl-2-feruloyl-diglucoside. As it is shown in Table 5, with 
bile acids involved in the digestion, fourteen compounds changed from non-bioaccessible to 
bioaccessible; whereas four compounds were bioaccessible, when no bile acids were in the 
digestion, and they changed to non-bioaccessible when bile acids are involved in the in vitro 
digestion. They are all kaempferol derivatives. Seventeen phenolic compounds are found in 
the kale digestion residue with bile acids involved in the digestion process. Among them, 
only eight polyphenols are found in the digested kale supernatant (see Table 5). The 
remaining compounds such as quercetin-3-O-sophoroside, kaempferol-3-hydroxyferuloyl-
diglucoside-7-diglucoside, kaempferol-3-O-diglucoside-7-O-glucoside, kaempferol-3-O-
sophotrioside only appear in the digested residue, indicating that they are not bioaccessible 
when bile acids are in the digestion. Fifteen phenolic compounds are found in the digested 
residue without bile acids involved in the digestion, in which ten compounds are only found 
in the digested residue, indicating that they are not bioaccessible, when bile acids are not 
involved in the digestive process (see Table 5).  
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Table 3. Identified polyphenols in raw kale from direct extraction and Soxhlet extraction  
RT 
/min 
Compound name Mol. 
Formula 
Exact 
mass 
ID Theratical 
Value 
Mass 
error 
(ppm) 
MS/MS fragment Soxhlet 
extraction 
Direct 
extraction 
15.4 Caffeoylqunic acid C16H18O9 731.1950 [2M+Na]+ 731.1799 20.6064 377, 215, 163 X X 
20 Quercetin-3-hydroxferuloyl-diglucoside-7-
glucoside 
C43H48O26 981.2325 [M+H]+ 981.2507 -18.5050 795, 633, 449, 287  X 
20.2 Quercetin-3-O (caffeoyl)-sophoroside-7-
glucoside 
C39H50O27 951.2249 [M+H]+ 951.2612 -38.1946 795, 571, 303, 163  X 
21.5 Quercetin-3-sinapyl-diglucoside-7-
triglucoside 
C50H60O31 995.2490 [M+H]+ 995.2663 -17.3903 553, 465, 369, 303, 207, 175  X 
22.1 Quercetin-3-O-(feruloyl)-sophoroside-7-O-
digulcoside (isomer) 
C49H58O29 1111.2990 [M+H]+ 1111.3137 -13.1844 523, 449, 339, 287, 177, 145, 117  X 
22.8 Quercetin-3-diglucoside-7-glucoside C33H40O22 789.2250 [M+H]+ 789.2084 21.0350 649, 465, 303 X X 
23.7 Quercetin-3-diglucoside-7-glucoside (isomer) C33H40O22 789.2230 [M+H]+ 789.2084 18.5008 649, 541, 465, 407, 303 X X 
23.9 Quercetin-3-sophoroside-7-diglucoside  C39H50O27 951.2790 [M+H]+ 951.2612 18.6773 649, 465, 347, 303 X X 
24.2 Quercetin-3-sophoroside-7-glucoside C33H40O22 789.1691 [M+H]+ 789.2084 -49.7955 705, 633, 492, 449, 411, 339, 303,   X 
26.1 Quercetin-3-O-(feruloyl)-sophoroside C43H48O25 965.2477 [M+H]+ 965.2557 -8.3325 909, 825, 685, 571, 523, 411, 339, 
303, 251, 177, 145, 89 
 X 
26.9 Quercetin- 3- feruloyl-diglucoside-7-
glucoside 
C43H48O25 965.2670 [M+Na]+ 965.2557 11.6622 825, 539, 465, 339, 303, 177 X  
27.1 Quercetin-3-sinapoyl-diglucoside-7-
diglucoside 
C50H60O31 1157.3330 [M+H]+ 1157.3191 11.9829 855, 553, 465, 369, 303, 207 X X 
27.5 Quercetin-3-feruloyl-diglucoside-7-
diglucoside 
C49H58O30 1127.3190 [M+H]+ 1127.3086 9.2548 825, 523, 465, 339, 303, 177 X X 
28.6 Quercetin-3-disinapoyl-triglucoside-7-
diglucoside 
C67H80O40 1525.4132 [M+H]+ 1525.4299 -10.9241 912, 737, 539, 457, 393, 303, 207, 
175, 91 
 X 
29.9 Quercetin-3-glucoside-7-O-glucoside C27H30O17 627.1600 [M+H]+ 627.1556 7.0541 303 X  
20.5 Kaempferol-3-O-sophotrioside-7-O-glucoside C42H46O24 957.2293 [M+Na]+ 957.2277 1.6966 633, 571, 439, 347, 287, 193  X 
20.8 Kaempferol-3-O-
(methoxycaffeoyl)sophoroside-7-O-glucoside  
C43H48O25 965.2390 [M+Na]+ 965.2557 -17.3457 539, 449, 355, 337, 287, 193, 161, 
133, 105 
 X 
21.2 Kaempferol-3-hydroxyferuloyl-diglucoside-
7-diglucoside 
C49H58O30 1127.2869 [M+H]+ 1127.3086 -19.2201 957, 539, 449, 355, 287, 193, 133, 
89 
 X 
23.9 Kaempferol-3-O-sophotoside-7-O-
diglucoside  
C42H46O24 957.2062 [M+Na]+ 957.2277 -22.4356 649, 561, 449, 411, 347, 287, 160, 
117 
 X 
24.1 Kaempferol-3-O-diglucoside-7-glucoside C33H40O21 773.2150 [M+H]+ 773.2135 1.9594 633, 449, 287 X  
25.4 Kaempferol – 3- hydroxyferuloyl-
diglucoside-7-glucoside 
C43H48O25 965.2710 [M+Na]+ 965.2557 15.8062 825, 633, 539, 449, 355, 287, 193 X  
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25.9 Kaempferol-3-O-(caffeoyl)sophoroside-7-O-
glucoside  
C42H46O24 935.2590 [M+H]+ 935.2663 -7.8138 795, 509, 449, 287, 163 X 
26.1 Kaempferol-3-hydroxyferuloyl-diglucoside-
7-diglucoside 
C49H58O30 1127.3250 [M+H]+ 1127.3086 14.5772 957, 825, 539, 449, 355, 287, 193 X 
26.7 Kaempferol-3-O-(caffeoyl)-sophoroside-7-O-
diglucoside  
C45H60O31 1097.3130 [M+H]+ 1097.3191 -5.5882 1017, 855, 795, 553, 409, 287 X X 
26.8 Kaempferol-3-O-(sinapoyl)-sophoroside C38H40O20 817.2058 [M+H]+ 817.2186 -15.6262 668, 593, 553, 523, 453, 411, 369, 
287 
X 
27.9 Kaempferol-3-O-(feruoyl)-sophoroside C37H38O20 803.1894 [M+H]+ 803.2029 -16.8326 523, 457, 409, 339, 287, 177,145, 
89 
X 
28 Kaempferol-3-O-(feruloyl)-sophoroside C37H38O19 787.2044 [M+H]+ 787.2080 -4.5795 619, 538, 442, 339, 287, 236, 176, 
105 
X 
28.2 Kaempferol-3-sinapoyl-diglucoside-7-
glucoside 
C44H50O25 979.280 [M+Na]+ 979.2714 8.7882 839, 553, 449, 369, 287, 207. X 
28.4 Kaempferol-3-sinapoyl-diglucoside-7-
diglucoside 
C50H60O30 1141.3310 [M+H]+ 1141.3242 5.9431 1001, 839, 633, 553, 449, 369, 
287, 207 
X X 
28.7 Kaempferol-3-(feruoyl)sophoroside-7-O-
glucoside 
C43H48O24 949.2680 [M+H]+ 949.2608 7.5543 809, 707, 523, 449, 339, 287, 177 X 
29.1 Kaempferol-3-feruloyl-digulcoside-7-
digucoside 
C49H58O29 1111.3320 [M+H]+ 1111.3137 16.5102 809, 523, 435, 339, 287, 177 X X 
29.2 Kaempferol-3-disinapoyl-triglucoside-7-
diglucoside 
C67H80O39 1509.4099 [M+H]+ 1509.4349 -16.5950 1115, 891, 737, 369, 287, 207, 
175, 91 
X 
30.9 Kaempferol-3-O-sophoroside C27H30O16 611.1650 [M+H]+ 611.1607 7.0996 287 X 
31.1 Disinapoyl-diglucoside C34H42O19 777.2083 [M+Na]+ 777.2218 -17.3670 603, 553, 531, 479, 393, 369, 287, 
207, 145, 91 
X 
31.3 1-sinapoyl-2-feruloyl-diglucoside C33H40O18 747.1982 [M+Na]+ 747.2112 -17.4422 603, 523, 339, 287, 207, 177, 145, 
89 
X 
32.9 Trisinapoyl-diglucoside C45H52O23 983.2719 [M+Na]+ 983.2797 -7.9398 759, 369, 285, 243, 207, 175, 91 X 
33.2 Disinapoyl-feruloyl-gentiobiose C44H50O22 953.2670 [M+Na]+ 953.2691 -2.2470 729, 535, 369, 207, 177, 91 X 
Continue Table 3 
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Table 4. Identified polyphenols in Soxhlet extracted fraction after incubation with bile acids 
RT/min Tentative identification MS (m/z);  ID MS ions (m/z of the main fragments) Formula  
15.7 Caffeoylquinic acid 377.2223 [M+Na]+ 264, 235, 163, 135, 117, 89 C16H18O9 
16.9 p-coumaroylquinic acid 699.1847 [2M+Na]+ 511, 361, 147, 119, 91 C16H18O8 
23.5 Quercetin-3-sophoroside-7-glucoside 789.504 [M+H]+ 649, 541, 347, 303 C33H40O22 
24.6 Quercetin-3-sophoroside-7-diglucoside 951.6187 [M+H]+ 795, 649, 465, 347, 303 C39H50O27 
24.9 Kaempferol-3-O-sophoroside-7-glucoside 773.5072 [M+H]+ 633, 571, 449, 347, 287 C36H36O19 
25.9 Kaempferol-3-O-(caffeoyl)sophoroside-7-O-glucoside  957.6164 [M+Na]+ 633, 449, 347, 287, 163 C42H46O24 
26.3 Kaempferol – 3- hydroxyferuloyl-diglucoside-7-glucoside 987.6139 [M+Na]+ 825, 539, 449, 355, 287, 193, 133 C43H48O25 
26.9 Kaempferol-3-O-(caffeoyl)sophoroside-7-O-glucoside  957.5905 [M+Na]+ 795, 509, 449, 287, 163, 135 C42H46O24 
27.1 Quercetin-3-feruloyl-diglucoside-7-diglucoside 1127.7371 [M+H]+ 957, 825, 539, 449, 287, 193, 84 C49H58O30 
27.7 Kaempferol-3-O-sophorotrioside-7-O-diglucoside  1097.7141 [M+H]+ 1017, 795, 553, 287 C45H60O31 
28.1 Quercetin-3-O-sinapoyl-diglucoside-7-diglucoside 1179.7539 [M+Na]+ 987, 855, 553, 369, 303, 207, 175 C50H60O31 
28.6 Quercetin-3-feruloyl-diglucoside-7-diglucoside 1127.7337 [M+H]+ 825, 523, 465, 339, 303, 177 C49H58O30 
29.3 Kaempferol-3-sinapoyl-diglucoside-7-glucoside 979.6311 [M+H]+ 839, 633, 553, 449, 369, 287, 207 C44H50O25 
29.8 Kaempferol-3-sinapoyl-diglucoside-7-diglucoside 1141.7498 [M+H]+ 971, 809, 707, 523, 435, 287, 177 C50H60O30 
30.2 Kaempferol-3-feruloyl-digulcoside-7-digucoside 1111.7294 [M+H]+ 809, 523, 339, 287, 177 C49H58O29 
23.3 Glycoholic acid 1396.927 [3M+H]+ 931, 488, 412, 337, 209, 91 C26H43NO6 
24.9 Cholic acid 1225.8692 [3M+H]+ 817, 431, 355, 239, 105 C24H40O5 
25.3 Glycochenodexoycholic acid 1348.9548 [3M+H]+ 899, 414, 339, 91 C26H43NO5 
25.7 Glycodexoycholic acid 1348.9505 [3M+H]+ 899, 450, 339 C26H43NO5  
27.6 Chenodeoxycholic acid 1177.8885 [3M+H]+ 785, 357 C24H40O4 
28.1 Deoxycholic acid 1177.8878 [3M+H]+ 823, 785, 415, 357, 247 C24H40O5 
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Bioaccessibility of Phenolic Compounds in Kale 
       Kaempferol was used as a molar equivalent to quantify kaempferol derivatives and 
quercetin was used as a molar equivalent to quantify quercetin derivatives. The preliminarily 
identified polyphenols in raw kale are shown in Table 3. In raw kale, the total quantified 
polyphenols were 3.01 mg/g and included 1.98 mg quercetin derivatives and 1.03 mg 
kaempferol derivatives. The tentatively quantified bioaccessible compounds are shown in 
Table 3. These are the compounds released into the supernatant after in vitro digestion, either 
with or without bile acids in the digestion. With bile acids in the digestion, a total of 2.09 
mg/g polyphenols was released into the supernatant, including 1.38 mg quercetin derivatives 
and 0.71 mg kaempferol derivatives. For the polyphenols in raw kale, with bile acids in the 
digestion, 69.4% of polyphenols were bioaccessible, 69.5% of quercetin derivatives were 
bioaccessible, and 69.1% of kaempferol derivatives were bioaccessible. With no bile acids in 
the digestion, we found 0.44 mg/g of polyphenols, and 0.05 mg of quercetin derivatives were 
bioaccessible and 0.39 mg of kaempferol derivatives were bioaccessible. Therefore, when no 
bile acids were in the in vitro digestion, 14.6% of identified polyphenols in kale were 
bioaccessible, and 37.7% kaempferol derivatives were bioaccessible, but only 2.7% of 
quercetin derivatives were bioaccessible.  
       In the residue of the digestion with bile acids, 0.37 mg/g polyphenols remain biostable, 
which means these polyphenols stay in the digested residue and not released into the 
digestive system. Among them, 0.18 mg are quercetin derivatives and 0.19 mg/g are 
kaempferol derivatives. Therefore, as is shown in Figure 10, with bile acids involved in the 
digestion, the biostability of quercetin derivatives was 9.2%, the biostability of kaempferol 
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derivatives was 18.0%, and 12.2% of total identified polyphenols were biostable. In the 
residue without bile acids, 0.37 mg/g of polyphenols remained biostable, among them 009 
mg/g quercetin derivatives and 0.14 mg/g kaempferol derivatives. Hence, when no bile acids 
were in the digestion, the biostability of quercetin derivatives is 4.2%, biostability of 
kaempferol derivatives is 12.0%, totally 6.8% identified polyphenols are biostable, as is 
suggested Figure 10.  
       Therefore, bile acids involved in the digestion can significantly improve the 
bioaccessibility of total identified polyphenols and quercetin derivatives. However, the 
bioaccessibility of kaempferol derivatives is slightly higher in the samples without bile acids 
in the digestion. This phenomenon probably is associated with the dietary fiber in kale. When 
the kale enters the human digestive system, our mouth and stomach work like an extractor for 
the polyphenols in kale. In our mouth, the kale is broken down mechanically; in our stomach, 
the acid helps to extract polyphenols in the vacuoles and weaken the link between 
polyphenols and the fiber. However, in the small intestine, the dietary fiber may act as an 
entrapping matrix to restrict the diffusion of polyphenols and limit their bioaccessibility.12 
Without bile acids in the digestion, dietary fiber can trap more polyphenols; when bile acids 
are added into the in vitro digestion, dietary fiber can bind more bile acids, which frees 
polyphenols and thus elevates the bioaccessibility of polyphenols. 
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Table 5. Phenolic compounds in kale from digestion supernatant (with/without bile acids incubation), and digestion residue 
(with/without bile acids incubation). 
RT [min] Description 
Raw Kale 
(mg/g) 
Supernatant 
without bile acids 
(mg/g) 
Supernatant with 
bile acids (mg/g) 
Residue without 
bile acids (mg/g) 
Residue with bile 
acids (mg/g) 
18.5 Quercetin-3-sophoroside-7-sophoroside  ND 0.025 ± 0.002 0.051 ± 0.001 0.026 ± 0.009  0.025 
19.1 Quercetin-3-sophoroside-7-glucoside 0.128 ± 0.016 ND 0.285 ±0.005 0.016 ± 0.002  0.053 ± 0.001 
19.9 Quercetin-3-triglucoside-7-glucoside 0.421 ± 0.018 ND 0.054 ± 0.001 ND ND 
19.7 Quercetin-3-sophororose-7-O-glucoside 0.087 ± 0.005 ND ND ND ND 
20.1 
Quercetin-3-hydroxferuloyl-diglucoside-7-
glucoside 0.051 ± 0.004 ND ND ND ND 
20.2 
Quercetin-3-O-(caffeoyl)-sophoroside-7-O-
glucoside 0.041 ± 0.003 ND 0.040 ± 0.010 ND ND 
21 
Quercetin-3-O-(feruloyl)-sophoroside-7-O-
glucoside (isomer) ND ND 0.387 ± 0.016 ND ND 
21.5 Quercetin-3-O-sophoroside ND ND ND ND 0.030 ± 0.001 
21.5 Quercetin-3-sinapoyl-diglucoside-7-glucoside 0.150 ± 0.013 ND ND ND 0.016 
21.6 Quercetin-3-sinapyl-diglucoside-7-diglucoside 0.520 ± 0.027 ND 0.235 ± 0.014 ND ND 
21.8 
Quercetin-3-O-(feruloyl)-sophoroside-7-O-
digulcoside  0.455 ± 0.032 0.028 ± 0.007 0.140 ± 0.010 0.024 ± 0.002  0.024 
22.2 Quercetin-3-glucoside-7-glucoside ND ND ND 0.016 ± 0.001  ND 
24.2 
Quercetin-3-O-(feruloyl)-sophoroside-7-O-
glucoside ND ND 0.020 ± 0.005 ND 0.041 ± 0.001 
24.4 
Quercetin-3-O-sinapoyl-diglucoside-7-O-
glucoside ND ND 0.037 ± 0.001 ND ND 
26 Quercetin-3-O-(feruloyl)-sophoroside 0.027 ± 0.002 ND 0.079 ND 0.030 ± 0.001 
28.6 
Quercetin-3-disinapoyl-triglucoside-7-
diglucoside 0.103 ± 0.004 ND 0.049 ± 0.002 ND ND 
16.9 Kaempferol-3-O-glucoside ND ND ND 0.004 ND 
19.7 Kaempferol-3-O-diglucoside-7-O-glucoside ND 0.074 ± 0.001 ND ND 0.009 ± 0.002 
20.3 Kaempferol-3-O-diglucoside-7-O-diglucoside ND 0.026 ± 0.001 0.014 0.007 ± 0.001  ND 
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20.3 Kaempferol-3-O-sophotrioside-7-O-glucoside 0.014 ± 0.001 ND ND ND ND 
20.7 
Kaempferol-3-O-(hydroxyferuloyl)-sophoroside-
7-O-glucoside 0.157 ± 0.005 ND 0.040 ± 0.002 ND 0.014 
21.2 
Kaempferol-3-O-(caffeoyl)-sophoroside-7-O-
diglucoside 0.019 ± 0.002 ND ND ND ND 
21.8 
Kaempferol-3-hydroxyferuloyl-diglucoside-7-
diglucoside 0.123 ± 0.004 ND ND ND 0.014 
21.5 Kaempferol-3-O-sophotrioside ND 0.018 ± 0.002 0.044 ± 0.001 ND 0.012 
22.1 Kaempferol-3-O-sophotrioside (isomer) ND ND ND ND 0.041 ± 0.001 
22.3 
Kaempferol-3-sinapoyl-diglucoside-7-O-
digulcoside  0.311 ± 0.006 ND 0.214 ± 0.007 0.009 ± 0.002  ND 
22.4 Kaempferol-3-feruloyl-digulcoside-7-digucoside 0.327 ± 0.010 0.171 ± 0.007 0.199 ± 0.005 0.008 0.038 ± 0.001 
23.1 Kaempferol-3-O-glucoside-7-O-glucoside ND ND ND 0.007 ± 0.001  ND 
23.6 Kaempferol-3-(feruoyl)-sophoroside-7-glucoside ND ND ND 0.006 ± 0.001  ND 
24.2 Kaempferol-3-O-diglucoside ND ND ND 0.018 ± 0.002  ND 
24.7 Kaempferol-3-(feruoyl)-sophorotriose ND 0.045 ± 0.002 ND 0.042 ± 0.004  ND 
25 
Kaempferol-3-(feruoyl)-sophoroside-7-
diglucoside (isomer) ND ND 0.054 ± 0.002 0.018 ± 0.006  0.017 ± 0.001 
25.3 Kaempferol-3-O-(sinapoyl)-sophorotriose ND ND 0.032 ± 0.001 ND 0.011 
26.8 
Kaempferol-3-O-(sinapoyl)-glucoside-7-
glucoside ND ND 0.033 ± 0.001 ND ND 
26.8 Kaempferol-3-O-(sinapoyl)-sophoroside 0.013 ND ND ND 0.012 
27.3 Kaempferol-3-O-(methoxycaffeoyl)-diglucoside ND ND ND 0.006 ± 0.001  ND 
27.4 Kaempferol-3-O-(feruoyl)-sophoroside 0.015 ± 0.001 0.051 ± 0.002 ND 0.022 ± 0.003  0.018 
27.7 Kaempferol-3-O-(feruloyl)-glucoside-7-glucoside ND ND 0.055 ± 0.002 0.004 ND 
28.4 
Kaempferol-3-(feruoyl)-sophoroside-7-
diglucoside (isomer) ND ND 0.007 ± 0.001 ND ND 
29.2 
Kaempferol-3-disinapoyl-triglucoside-7-
diglucoside 0.035 ± 0.003 ND 0.017 ± 0.001 ND ND 
31.1 Kaempferol-3-O-(feruloyl)-sophoroside (isomer) 0.011 ± 0.001 ND ND ND ND 
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Figure 10. Bioaccessibility (A) and biostability (B) of kaempferol derivatives, quercetin 
derivatives and total identified polyphenols after the in vitro digestion with / without bile 
acids. 
 
 
Conclusion 
       After Soxhlet extraction of kale, the residue was 71% of the original weight and after 
Soxhlet extraction, total dietary fiber increased 18%, soluble fiber increased 64%, and 
insoluble fiber increased 9%. However, 0.71 g of the residue showed similar binding capacity 
to that of 1.0 g raw kale for glycocholate, cholate, glycochenodeoxycholate, 
chenodeoxycholate, and deoxycholate. Yet, 0.71 g of extraction residue bound more 
glycodeoxycholate than 1.0 g of raw kale. This suggested that the main part in kale that 
contributes to bile acid binding is the fiber-rich tissue. Polyphenols in kale are quercetin 
derivatives, kaempferol derivatives, and caffeoylquinic acid acid. These polyphenols do not 
bind bile acids, but may interact with bile acids through intermolecular force. Bile acids in 
the digestion significantly increase the bioaccessibility of quercetin derivatives, and total 
identified polyphenols, but slightly reduced the bioaccessibility of kaempferol derivatives. 
[B] 
 
[A] 
 [A] 
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CHAPTER V 
SUMMARY 
 
       Bile acids assist in the digestion of fatty foods, are reabsorbed through the ileum, and can 
be transferred back to the liver via the enterohepatic circulation. Binding of bile acids by 
foods can reduce bile acid reabsorption and promote synthesis of new bile acids from 
cholesterol, which can lower cholesterol levels and prevent cardiovascular disease. The bile 
acid binding capacity of red kale, green kale, red leaf lettuce, Brussels sprouts, and red 
cabbage were examined through in vitro digestion. These vegetables’ binding capacity for 
total and individual bile acids was analyzed by HPLC. The results showed that green kale 
and red kale have higher in vitro bile acid binding capacity than the rest of the vegetables. 
Also, kale preferentially binds hydrophobic bile acids, deoxycholic acid, and 
chenodeoxycholic acid. However, green kale was chosen for further study, since it has more 
phenolic compounds than red kale.  
       Different bile acid compositions were used to test green kale’s bile acid binding 
capacity. Kale shows similar binding capacity in the mixture mimicking the bile acid 
composition of a male with gallstones and a healthy female, but it binds fewer bile acids in 
the composition simulating the bile of a male with type-2 diabetes. In the type-2 diabetic 
male’s bile acid composition, green kale can bind no more than 81.8% of total bile acids and 
theoptimal dose for this maximal binding capacity is 1.31 g dry weight in this experiment. 
Considering this result and the data from previous clinical trials,57, 96 green kale can bind no 
more than 51.6% of bile acids in the human body, which would need 55.6 g green kale (dry 
matter) or 427.0 g fresh kale. Considering that 427.0 g fresh kale is likely too much for daily 
consumption, lyophilized kale snacks may be a better choice.  However, most of the kale 
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chips in the market are fried and flavored with sugar, which may cause additional problem to 
hypercholesterolemia it is wiser to choose freeze dried kale snacks. 
       Microwave heating of kale for 1 or 3 min can significantly improve kale’s in vitro bile 
acid binding capacity. This may be because heating changed the structure of the protein and 
dietary fiber complex. Dietary fiber can bind bile acids, and ample evidence30, 85, 97 indicates 
that when protein is separated from the dietary fiber complex, this increases the available 
surface of the fiber for more bile acid binding.31 However, dietary fiber from different 
vegetables shows different bile acid binding capacities. For example, each gram of dietary 
fiber from red cabbage can bind 84.2 mg of bile acids, but each gram of dietary fiber from 
red leaf lettuce can bind 109.2 mg of bile acids. Other compounds in the vegetables might 
increase the bile acid binding capacity of the dietary fiber.  
       To better understand the interaction of other bioactive compounds with bile acids, kale 
was used for further study. Lyophilized kale was extracted with a Soxhlet apparatus, and the 
polyphenols were separated from the dietary fiber. The polyphenols were characterized by 
ultra-high-performance liquid chromatography-time-of-flight-mass spectrometry (LC-QTOF-
MS). Twenty-seven polyphenols were found in the raw kale, including nine quercetin 
derivatives, thirteen kaempferol derivatives, four sinapoyl derivatives, and caffeoylquinic 
acid.  
To test whether polyphenols contributed to bile acid binding, the fiber-rich tissue and 
extracted phenolic compounds were incubated with bile acids. The results indicated that bile 
acids are mainly bound by the fiber-rich tissue, rather than by phenolic compounds. 
Polyphenols attaching to bile acids can form novel molecules. However, the polyphenols 
may still interact with bile acids through intermolecular force and contribute to bile acid 
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binding. In addition, bile acids in the digestive process can improve the bioaccessibility of 
polyphenols, which mayoccur when bile acids are bound to the dietary fiber in the kale, 
because dietary fiber released polyphenols and increased their bioaccessibility. 
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APPENDIX A 
 
 
Table S1.  Chemical composition of simulated saliva fluid prepared for the bile acid binding 
assay53 
 
Chemicals (g/l) 
Sodium chloride 1.594 
Ammonium nitrate 0.328 
Potassium dihydrogen phosphate 0.636 
Potassium chloride 0.202 
Potassium citrate 0.308 
Uric acid sodium salt 0.198 
Lactic acid sodium salt 0.146 
Porcine gastric mucin 1.000 
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Table S2. Different bile acids compositions used in the present study to mimic the various 
human health conditions98 
 
    
Bile acid 
BAC-1  
(mM) (%) 
BAC-2 BAC-3  
(mM) (%) (mM) (%) 
Glycocholate 1.24 (3.1) 1.2 (3.1) 1.24 (3.1) 
Cholate 12.1 (30.2) 12 (30.0) 13.2 (30.2) 
Glycochenodeoxycholate 5.1 (12.8) 2.56 (6.4) 5.1 (12.8) 
Glycodeoxycholate 2.5 (6.3) 2.5 (6.3) 2.6 (6.3) 
Chenodeoxycholate 11.6 (29.0) 17.4 (43.5) 5.8 (14.5) 
Deoxycholate 7.4 (18.6) 4.28 (10.7) 13.7 (33.0) 
 
BAC-1: male with gallstone 
 
BAC-2: healthy female 
  
BAC-3: type 2 diabetes  
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Table S3. Moisture content in fresh vegetables, total fiber, and lyophilized amount used for 
bile acid binding assay 
 
Vegetables 
Moisture 
(%) 
Dried sample 
used for bile 
acid binding   
(g)  
Total 
fiber 
(%) 
Equivalent 
to fresh 
weight (g) 
Total bile 
acid 
binding 
(%) 
Red kale 87.29 2 40 15.74 89.73 
Red leaf lettuce 95.64 2 31.5 45.87 78.06 
Green kale total 89.08 2 39.5 18.32 86.5 
Green kale leaf 86.98 2 38.1 15.36 81.40 
Brussels sprouts 84.36 2 30.4 12.79 62.09 
Red cabbage 91.29 2 30.3 22.96 57.91 
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Table S4. Fiber content of lyophilized green kale and Soxhlet extracted green kale residue 
Sample 
Total 
dietary 
fiber % Soluble fiber % Insoluble fiber % 
Lyophilized Green Kale 39.5 6.6 32.9 
Soxhlet extracted residue of 
Green kale  46.6 10.8 35.8 
71% Soxhlet extracted 
residue of Green Kale 33.1 7.5 25.4 
 
 
 
 
 
